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1  INTRODUCTION 
 
 
1.1  ALUMINIUM 
1.1.1  The element 
Aluminium is the thirteenth element of the periodic table and it belongs to group 13. 
It was discovered by Davy in 1805 and it was isolated for the first time by Örsted in 
1825. Approximately 8 % of Earth crust contains Aluminium, and this element is the 
third most abundant element after oxygen (47%) and silicon (28%). Table 1.1 lists 
some properties of Aluminium. 
Table 1.1: Aluminium properties 
Atomic mass (m.a.u.)  26.982 
Atomic ray (calc.) (pm)  125 
Electronic configuration  [Ne]3s
23p 
Oxidation states  III 
Melting point (°C)  660.33 
Boiling point (°C)  2467 
Evaporation heat (kJ/mol)  293.4 
Fusion heat (kJ/mol)  10.79 
Electro-negativity  1.61 
Natural isotopes  26, 27 
Synthetic isotopes  23, 24, 25, 28, 29, 30 
 
The element in its lowest oxidation state (zero) is very reactive; for this reason it can 
be found in nature just as Al
3+, forming compounds like oxides, silicates, sulphates 
and phosphates which can be found mostly in clays, feldspar, cryolite and bauxite. 
Bauxite is the raw material used to extract aluminium for its industrial production. 
Thanks to its corrosion resistance (due to the formation of an oxide protective film) 
and to its ability to form light alloys, aluminium in its metallic form can be used in  
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several  applications.  Even  its  ionic  form  is  important  for  many  applications: 
aluminium sulphate is used as a flocculant in water purification, alkyls-aluminium 
are involved in the catalytic process in Ziegler–Natta polymerizations, aluminium 
chloride is contained in deodorants as antiperspicant, aluminium hydroxide is used in 
toothpastes as abrasive, and several aluminium compounds are found in anti-acid 
medicines  and  in  the  treatment  of  hyperphosphatemia,  a  disease  which  affects 
patients with chronic renal deficiency [Willis 1983].  
In  natural  water  the  concentration  of  Al
3+  is  very  low,  about  10
–8  M  in  neutral 
conditions;  this  value  increases  by  changing  the  pH  and  with  the  presence  of 
complexing  agents,  like  inorganic  anions  (fluoride  and  phosphates)  or  organic 
compounds (humic and fulvic acids). Aluminium solubility especially increases with 
decreasing  pH,  as  evidenced  by  the  greater  dissolution  extent  of  the  metal  from 
minerals  observed  in  recent  decades  due  to  the  increase  of  rain  acidity.  This 
phenomenon has increased aluminium bioavailability in natural water [Zatta 1995]. 
1.1.2   Aluminium speciation in aqueous solutions  
Several studies were carried out to study aluminium speciation in aqueous solutions, 
but results are often very different each other, due to the multiplicity of compounds 
forming in the solution, the slowness of reactions, and the formation of metastabile 
species.  
At acidic pH, Al
3+ is found exclusively as [Al(H2O)6]
3+, an octahedral exahydrate ion 
usually written as Al
3+. Starting from pH above 3.5, Al
3+ is involved in hydrolysis 
reactions which lead to the loss of H
+ ions from the coordinated water molecules. 
The species Al(OH)
2+, Al(OH)2
+, Al(OH)3 and Al(OH)4
– [Martin 1986] are formed. 
Al(OH)3  is  slightly  soluble  ,  so  it  undergoes  precipitation  at  pH  about  4,  but  it 
dissolves again at basic pH (about 11) after the formation of tetrahydroxoaluminate. 
If  Al
3+  concentration  is  high  enough,  at  neutral  pH  the  formation  of  several 
polymeric species can occur, in which hydroxyl ions connect two or more metal ions; 
the formation kinetics of these polymers is very slow (months or years). For this 
reason, these species have not been univocally characterized yet. The most reliable 
speciation model is the one proposed by Öhman, referred to an environment of NaCl 
0.6 M [Ohman 1988]. Table 1.2 reports the stoichiometry and formation constant of 
the identified aluminium hydroxo-complexes.  
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Table 1.2: stoichiometry and formation constant of identified aluminium hydrolysis products, 
and solubility product of amorphous and crystalline aluminium hydroxide [Ohman 1988]. 
(Constants refer to the equilibrium mAl + nH2O ⇌ Alm(OH)n + nH
+) 
Species  log β 
Al(H2O)6
3+  --- 
Al(OH)
2+  –5.52 
Al(OH)2
+  –11.3 
Al(OH)3  –17.3 
Al(OH)4
–  –23.46 
Al3(OH)4
5+  –13.57 
Al13(OH)32
7+  –109.2 
Al(OH)3(amorphous)  pKs = 10.8 
α–Al(OH)3  pKs = 9.2 
 
Observed pKa referring to consecutive hydrolysis of Al
3+ are lower than the ones 
expected by electrostatic and statistic considerations. This can be explained on the 
basis  of  the  progressive  decrease  of  the  Al
3+  coordination  number  of  from  6 
(Al(H2O)6
3+)  to  4  (Al(OH)4
–),  which  shortens  the  Al-O  bond.  Consequently,  the 
deprotonation of coordinated water molecules is facilitated, because of their higher 
acidity [Martin 1986]. The proved pentacoordination of aluminium in the complex 
Al(OH)
2+ [Swaddle 2005] further confirms this hypothesis. 
1.1.3  Complex formation between aluminium(III) and ligands: 
thermodynamic aspects 
In the presence of a ligand, Al
3+ can form many complexes, in addition to the ones 
previously mentioned. Thanks to its strong localized charge and small ionic radius, 
aluminium(III) is considered a hard Lewis acid. Therefore it presents a good affinity 
for Lewis bases of the same type, which include, in particular, functional groups 
containing negatively charged oxygens. The strongest interactions are observed with 
organic species like alkoxides (R-O
−), phenoxides (Ar–O
–), hydroxamic acids (N–O
–
) and carboxilate (COO
–) ions; interactions with carboxy groups are significant only 
if oxygen is significantly negatively charged thanks to the resonance form C–O
–. As 
regards inorganic ions, Al
3+ affinity is high towards SO4
2–, SiO4
4–, and especially  
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towards PO4
3– and F
–. The stability of the complexes increases with the number of 
coordination sites of the binder: the stability can be very high if the ligand is able to 
form  a  polydentate  chelation  ring  with  5  or  6  terms.  However,  at  basic  pH  all 
complexes are destabilized due to the formation of the species Al(OH)4
–. 
1.1.4  Complex formation between aluminium (III) and ligands: kinetic aspects 
The complexation reactions involving Al
3+ go generally to completeness within some 
seconds. This time value is much larger than that required for many other metal ions 
(usually 10
–6–10
–7 seconds), but it is lower than that of Cr
3+ and Co
3+ (10
6 and 10 
seconds,  respectively),  which  are  the  most  inert  metal  ions.  The  kinetics  of 
substitution of the solvent from the metal depends also on the type of the ligand [Kiss 
1996].  The  substitution  of  the  ligand  from  the  metal  centre  seems  to  follow  an 
interchange dissociative mechanism (D), whereby a dissociation is required before a 
new  ligand  molecule  may  coordinate.  This  mechanism  agree  with  the  small 
dimensions of Al
3+ [Hugy 1985]. In the first step a ionic couple is formed; this is the 
rate  determining  step.  The  loss  of  a  water  molecule,  and  the  formation  of  the 
complex (1.1), occur after the first step:  
 
Al(H2O)6
3+ + HL  ⇌   Al(H2O)6(HL)
3+ 
Al(H2O)6(HL)
3+ →  Al(H2O)5(HL)
3+ + H2O    (1.1) 
Al(H2O)5(HL)
3+  → Al(H2O)5L
2+ + H
+ 
 
It is worth nothing that the only available kinetic information in aluminium-ligand 
reactions  have  been  obtained  at  acidic  pH,  or  regards  very  strong  mononuclear 
complexes. This because at neutral pH, and/or if the complexes are not very stable, 
hydroxo-complexes and metastabile species can form (see paragraph 1.1.2), which 
strongly complicates the speciation in solution.  
1.1.5  Biochemistry and toxicity of aluminium 
Aluminium is commonly present in beverages such as tea, coffee and water (thanks 
to  the  depuration  processes  with  aluminium  sulphate).  Aluminium  can  also  be 
assimilated through cooking food in aluminium pans, vaccines and body deodorants 
which contain aluminium chlorohydrates [Crisponi 2012 (a)]. The daily amount of 
aluminium introduced with diet is about 5–50 mg [Ganrot 1986]. A higher amount is 
introduced  with  antiacids  drugs,  gel  for  hyperphosphatemia  treatment,  and  food 
additives  such  as  E173  (metallic  aluminium),  E541  (sodium  and  aluminium  
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phosphate), E554 (sodium and aluminium silicate), E556 (Calcium and aluminium 
silicate).  
When  aluminium  enters  the  circulatory  system,  it  is  complexed  by  transferrin,  a 
protein  devoted  to  transport  iron  inside  the  organism.  The  ion  is  then  removed 
through  kidney  dialysis  and,  in  a  little  amount,  through  feces  excretion.  The 
remaining part is accumulated mainly in brain, bones, lungs and milt [Zatta 1995]. 
Several  clinical  and  epidemiological  studies  evidenced  a  correlation  between 
aluminium storage in the organism and the onset of some human diseases; these 
affect almost exclusively uremic patients who undergo dialysis, and they are dialysis 
dementia, vitamin D-resistant osteomalacia, and microcytic anemia (not dependent 
on iron). 
Dialysis  dementia  is  a  neurological  disease  characterized  by  the  increase  of 
aluminium in the brain up to 20-30 times compared to a healthy  person. [Alfrey 
1980]. It leads to personality changes, psychosis and dementia until death, which 
may occur even in few months. At the base of the disease there is the inability to 
eliminate aluminium by renal excretion, so the accumulation increases up to toxic 
levels. Furthermore, in dialysis patients the metal also comes from the gel used to 
control  hyperphosphatemia  and  dialysis  water,  which  enters  directly  into  the 
bloodstream  without  passing  through  the  gastro-intestinal  barrier.  To  avoid  this 
problem, deionized dialysis water and filters are being used nowadays.  
Vitamin D-resistant osteomalacia is a disease characterized by bone fragility and 
musculo-skeletal pain, caused by the increased amount of aluminium in bones and 
brain [Alfrey 1980]. In the bone tissue level, the ion is  gradually internalized in 
osteoblasts,  which  have  several  exposed  transferrin  receptors  on  their  plasma 
membrane. Inside these cells, the metal plays an antiproliferative role by inhibiting 
the  synthesis  of  bone  matrix,  to  which  osteoblasts  would  be  devoted  in  healthy 
organisms [Silverthorn 2007]. 
Microcytic anemia is a disease that affects the hematopoietic system of patients with 
uremia. It causes a significant reduction in the size of red blood cells. This anemia is 
called “iron independent” because it is not caused by iron deficiency. 
 
1.2  ZINC 
1.2.1  The element  
Zinc is present on Earth crust at an amount equal to 132 ppm and it is the 24
th most 
abundant element. Crustal Zn is mainly bound with sulphur as zinc sulphide (ZnS).  
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Its structure is similar to the diamond one, with half of the positions occupied by S, 
and half by Zn. 
Zinc is mainly used as antirust metal: a thin zinc layer covers iron and other metals to 
avoid rust. Zinc is used also to obtain alloys: the most common zinc alloy is brass 
(Cu/Zn  containing  20-50%  of  zinc).  Among  the  ionic  compounds,  ZnO  is  the 
commercially  important  one,  because  it  is  used  as  white  pigment  in  paints,  in 
cosmetics,  as  deodorizing  and  antibacterial  agent  in  baby  powders,  and  as  zinc 
source in food. Some properties of Zinc are listed in Table 1.3. 
 
Table 1.3: zinc properties 
Atomic mass (m.a.u.)  65.409 
Atomic ray (calc.) (pm)  142 
Electronic configuration  [Ar]3d
104s
2 
Oxidation states  II 
Melting point (°C)  420 
Boiling point (°C)  907 
Evaporation heat (kJ/mol)  115.3 
Fusion heat (kJ/mol)  7.322 
Electro-negativity  1.65 
Natural isotopes  64, 66, 67, 68, 70 
Synthetic isotopes  65, 72 
 
Zinc has two electrons belonging to an s orbital, and a full d orbital. The removal of 
the s electrons gives compounds with the characteristic oxidation state (+II). There is 
no  evidence  for  the  existence  of  oxidation  states  higher  than  (+II),  because  the 
removal of more electrons would destroy the symmetry of a complete d shell. Zinc is 
a soft metal, probably because d electrons do not participate to metallic bond.  
Zinc is a silvery metal, and it is oxidized easily by humid air; it dissolves in diluted 
non-oxidant acids forming hydrogen; it reacts with oxidant acids like concentrated 
HNO3  and  H2SO4,  forming  salts,  sodium  oxides  and  SO2.  Furthermore,  zinc  has 
amphoteric  properties  and  it  is  soluble  in  alkali  forming  zincates  with  formulas  
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[Zn(OH)4]
2−  and  [Zn(OH)3]
−.  By  heating,  the  metal  forms  the  oxide  ZnO,  the 
insoluble sulphide ZnS, and halides ZnX2. [Lee 1996] 
1.2.2  Zinc speciation in aqueous solutions 
The hydrolysis behaviour of Zn
2+ is not completely sure due to some inconsistencies 
existing in the extensive literature on this ion. Some of the apparent disparity, is 
probably due to small complexing effects in the different media employed. While 
there is a general consensus (among the potentiometric studies) for the existence of 
ZnOH
+ and Zn2OH
3+ in small amounts, the solubility and solvent extraction results 
indicate  the  possible  formation,  with  very  different  stabilities,  of  Zn(OH)2, 
Zn(OH)3
−, Zn(OH)4
2− and Zn2(OH)6
2−. In any case, Zn
2+ hydrolyzes only sparingly 
before precipitation of the poorly soluble Zn(OH)2 which commences in the neutral 
region.  The  fresh  precipitates  produced  from  zinc  salt  solutions  are  usually  the 
amorphous Zn(OH)2 or ZnO, which will subsequently change to a more stable form 
upon aging. In some cases mixed precipitates which have not been well characterized 
can  form.  The  formation  constants  of  zinc  hydroxo-complexes  estimated  in 
perchlorate media at 25 °C are listed in Table 1.4.  
 
Table 1.4: formation constants of zinc hydrolysis products, and solubility product of zinc oxide 
and hydroxide. [Charles 1976] (constants refer to the equilibrium  
mZn + nH2O ⇌ Znm(OH)n + nH
+) 
Species  Log β 
ZnOH
+  −8.96 
Zn(OH)2  −16.9 
Zn(OH)3
−  −28.4 
Zn(OH)4
2−  −41.2 
Zn2OH
3+  −9.0 
Zn2(OH)6
2−  −57.8 
ZnO(prec.)  pKs=11.31 
Zn(OH)2(amorphous)  pKs=12.45 
   
1.2.3  Complex formation between zinc (II) and ligands: structural and 
thermodynamic aspects 
Zn
2+ ion does not have stabilizing effects of the ligand field, because its d shells are 
complete.  The  stereochemistry  of  its  compounds  is  then  governed  only  by  size,  
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electrostatic  forces,  and  covalent  bonding  forces.  As  regards  the  coordination 
number, it can be noted that ZnO crystallizes in a lattice in which the Zn
2+ ions are 
situated  in  tetrahedral  cavities  surrounded  by  four  oxide  ions.  Similarly,  ZnCl2 
crystallizes in  not  less than three allotropic forms, at  least  two of which contain 
tetracoordinated  zinc  atoms.  A  commercially  available  Zn
2+  compound  is  nitrate, 
which  can  be  obtained  with  different  hydratation  forms,  among  which 
Zn(NO3)2·6H2O  is  the  most  common.  Similarly,  it  is  possible  to  isolate  salts 
containing [Zn(NH3)6]
2+ from reactions done in liquid NH3, e.g. ZnCl2·6NH3. So, the 
coordination number 6 is common. Anyway the coordination number 4 is also often 
observed; for example in aqueous solutions, [Zn(NH3)6]
2+ exists in equilibrium with 
tetrahedral [Zn(NH3)4]
2+. As well, coordination number 5 can occur in several salts, 
as e.g. Zn(acac)2·H2O in which the coordination of Zn
2+ is square-based pyramidal 
[Housecroft 2005].  
Zinc  dithiocarbamates  complexes  and  other  sulfur  compounds  are  important 
accelerators in the vulcanization of rubber with sulfur. Dithiocarbamates form 1:1 
pentacoordinated  complexes  with  amines  [Coates  1967].  The  zinc  β-dichetonates 
also  form  1:1  pentacoordinated  adducts  with  nitrogenous  bases  [Graddon  1964]. 
Examples of high coordination numbers for Zn
2+ are rare, but include pentagonal 
bipyramidal  [Zn(15-crown-5)(H2O)2]
2+,  and  dodecahedral  [Zn(NO3)4]
2−  [Albert 
1967].  Some  examples  of  the  different  structures  and  coordination  numbers 
displayed by Zn
2+ complexes are reported in Table 1.5 [Albert 1967]. As regards 
thermodynamics,  Zn
2+  is  a  borderline  hard/soft  ion  and  readily  complexes  with 
ligands containing a range of donor atoms, e.g. borderline N-, hard O- and soft S-
donors. At the same time, the complexes formed by this metal ion are generally not 
extremely stable. 
 
Table 1.5: zinc stereochemistry [Albert 1967] 
Coordination 
number  Geometry   
Examples 
2  Linear  Zn(CH3)2 
4  Tetrahedral 
[Zn(CN)4]
2−, 
ZnCl2(s), 
Zn(NH3)2Cl2 
5 
Distorted trigonal-
based bipyramidal or 
square-based 
pyramidal 
ZnCl2, 
Zn(acac)2·H2O 
6  Octahedral  [Zn(NH3)6]
2+ 
(crystals) 
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1.2.4  Complex formation between zinc (II) and ligands: kinetic aspects 
There  are  relatively  few  data  for  substitution  reactions  involving  Zn
2+.  Some 
measurements, e.g. those for the Zn
2+-bpy system, strongly evidence the Id character 
in the substitution. When the interchange is concerted and there is partial, and equal, 
association and dissociation of the entering and leaving groups, the mechanism is 
termed I. This  will rarely occur and more likely there will be a preference for Ia or Id, 
in  which  the  entering  and  leaving  groups  are  either  firmly  (Ia)  or  weakly  (Id) 
embedded in the coordination sphere of the metal. In the interchange mechanism, 
there  is  an  interchange  of  H2O  and  L  perhaps  within  an  outer-sphere  complex 
(MH2OL) which is very rapidly formed from the reactants as shown in scheme 
(1.2) [Wilkins 2002]: 
 
ZnH2O + L   ⇌    ZnH2OL   k1, fast 
ZnH2OL   ⇌    ZnLH2O   k2          (1.2) 
ZnLH2O   ⇌    ZnL + H2O   fast 
 
The water exchange rate constants for several metal ions are shown in Figure 1.1. 
The water exchange constant for Zn
2+ is about 10
7 s
−1, which represents a mean value 
compared with those of many other metal ions. However, it is 10
7 larger than that of 
Al
3+. 
 
Figure 1.1: rate constants (s
−1) for water exchange of metal cations, measured directly by NMR 
or estimated from the rate constants for complex formation [Wilkins 2002]. 
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1.2.5  Biochemistry and toxicity of zinc 
Since the 1920-1930s the essentiality of this element for the growth of plants and 
animals  had  been  recognized.  However,  only  in  the  ‘60s  it  was  shown  that  this 
element  is  essential  also  for  humans  [Pories  1966].  It  is  a  component  of  many 
enzymes in the liver, pancreas, kidney and other organs. It is estimated that more 
than  one-third  of  human  enzymes  contain  metals  [Guengerich  2009].  They 
participate in a wide variety of biochemical processes in the cells. The equilibrium 
distribution  of  metal  ions  is  crucial  for  many  physiological  functions.  Enzymes 
containing Zn take part in many metabolic processes like synthesis and degradation 
of carbohydrates, lipids, proteins and nucleic acids.  
Some human disease, such as delays and abnormalities in the growth, appear to be 
linked to zinc deficiency. It was also demonstrated the therapeutic importance of zinc 
in the treatment of dermatitis enteropathica. Some recent studies suggest a protective 
effect of zinc against the action of some toxic heavy metals [Abdulla 1979]. The total 
body content of zinc is about 2-2.5 g. The highest concentrations are present in the 
choroid of the eye, in the prostate, and about 20% of the total content is contained in 
the skin. This element is present in blood mainly in red blood cells (80%), but also in 
white blood cells and platelets. About 60% of the plasmatic zinc is bound weakly to 
albumin and performs the function of protein carrier, while less than 10% is bound to 
amino  acids  (hystidine  and  cysteine)  and  only  a  small  fraction  is  bounded  to 
transferrin.  
Ingestion is the most common way to assume zinc and its absorption occurs in the 
duodenum at an amount of 20-30 % of the ingested. The absorption, as for most of 
the metal ions, is influenced by age, sex, state of nutrition, level of zinc in the diet, 
and also by the presence of certain antagonists such as calcium, phosphates, and 
chelating agents. Most of the zinc that is not absorbed is excreted with faeces. 
In addition to the protective action previously cited, zinc also acts by blocking the 
formation of free radicals resulting from the oxidation of iron: according to recent 
studies, Zn
2+ is interposed, during the oxidation of iron, between the latter and thiol 
groups, thus preventing the formation of free radicals [Wilson 1987]. In dependence 
of this (but it has not been shown in which way) zinc deficiency would be related to 
some tumour diseases [Wilson 1977]. 
Despite  the  essentiality  of  zinc,  in  high  doses  it  becomes  toxic  and  disturbs  the 
metabolism  beginning  with  inhibition of mitochondrial respiration leading to  cell 
failure.  Experimental  studies  reveal  that  metallothionein,  a  protein  that  binds  to 
heavy metal through the thiol group of cysteine residues, favours zinc adsorption. 
Metallothionein  binds  copper  stronger  than  zinc,  but  in  excess  of  zinc,  copper 
absorption is low. In the case of excess of zinc intake, copper deficiency is possible  
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[Brilla 2005]. The antagonistic effect between Zn and Cu or Fe is confirmed by 
several studies, which show that copper and iron concentration decreases after zinc 
excess administration [Prejbenau 2011]. 
 
1.3  COPPER 
1.3.1  The element 
Copper  is  rather  abundant  as  it  is  the  25
th  element  on  the  Earth.  Its  mean 
concentration on Earth crust is 68 ppm by weight. The most common mineral is 
chalcopyrite  CuFeS2,  but  also  basic  cuprum  carbonate  CuCO3·Cu(OH)2,  cuprous 
oxide  Cu2O  and  Cu5FeS4  are  found.  Sulphide  minerals  are  often  poor  in  metal 
concentration and can contain only 0.4 % of copper; for this reason minerals are 
extracted and exposed to air. CuS it slowly oxidized to CuSO4, which is washed 
away with water or diluted H2SO4. Copper is separated from the resulting solution of 
copper sulphate by the addition of scrap iron, which forms metallic copper according 
to the reaction 1.3. 
 
Fe  + Cu
2+    →     Fe
2+  +  Cu           (1.3) 
 
The metal is used in the electrical industry for its high conductivity, and is also used 
for water pipes due to its low reactivity. Over than 1,000 different copper alloys are 
known: the most used is brass. Different copper compounds are used in agriculture to 
prevent the attack of fungi or insecticides. Some properties of copper are listed in 
Table 1.6. 
Table 1.6: copper properties 
Atomic mass (m.a.u.)  63.546 
Atomic ray (calc.) (pm)  145 
Electronic configuration  [Ar]3d
104s
1 
Oxidation states  I, II, (III) 
Melting point (°C)  1083 
Boiling point (°C)  2570 
Evaporation heat (kJ/mol)  300.3 
Fusion heat (kJ/mol)  13.1  
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Electro-negativity  1.9 
Natural isotopes  63, 65 
Synthetic isotopes  64 
 
The metals belonging to the copper group have the highest known electrical and 
magnetic conductivity, and are the most malleable and ductile. These properties are 
due to their cubic compact structure: when a sufficient force is applied, a floor can 
slip over another one;  thanks  to  the simplicity  of the structure,  after the relative 
movements of the floors, the structure is again a cubic compact one. 
Copper has one s electron in its external orbital. Nevertheless, the oxidation state (+I) 
is not very stable and Cu
+ undergoes disproportionation in water (see also below) 
unless this ion is strongly stabilized in a suitable chemical form. Cu
2+ is reduced to 
Cu2O by weak reducing agents. Cu2O is a basic oxide, that reacts with halohydric 
acids HCl, HBr and HI, resulting in insoluble CuCl, CuBr and CuI. Cu
+ forms many 
polymeric complexes,  with  a cluster made of four Cu atoms  at the vertices  of a 
tetrahedron, but without metal-metal bonds. 
The state (+III) is not common for copper. In alcaline solutions, Cu
2+ can be oxidized 
to KCu
IIIO2; if a molten mixture of KCl/CuCl2 is fluorinated, K3[Cu
IIIF6] is formed. 
Strong oxidation with periodic acid (H5IO6) gives K7Cu
III(IO6)2·7H2O. 
The state (+II) is the most common and stable for copper. Rameic ion Cu
2+ has the 
electronic configuration d
9 and has an unpaired electron: therefore, its compounds 
are paramagnetic and thanks to d-d transitions they are also coloured. Most copper 
complexes like halides CuX2, and complexes formed with ammonia and amines in 
aqueous solution, have an octahedral distorted structure. This is due to the Jahn-
Teller effect.  
1.3.1.1  Jahn-Teller effect 
When the metal cation Cu
2+ is surrounded by six ligands placed on the Cartesian 
axes at the vertices of an octahedron, an electrostatic attraction between the metal ion 
and ligands can be supposed. However, there is also a repulsive interaction between 
electrons in the d orbitals and the ligand charges. If the electrostatic field (the crystal 
field)  were  spherical,  then  the  energies  of  the  five  3d  orbitals  would  be  raised 
(destabilized) by the same amount. However, since the dz2 and dx2−y2 atomic orbitals 
point directly at the ligands while the dxy, dyz and dxz atomic orbitals point between 
them, the dx2 and dx2−y2 atomic orbitals are destabilized to a greater extent than the 
dxy, dyz and dxz atomic orbitals (Figure 1.2). Thus, the dz2 and dx2−y2 atomic orbitals  
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are destabilized while the dxy, dyz and dxz atomic orbitals are stabilized. The Jahn-
Teller theorem states that any non-linear molecular system in a degenerate electronic 
state  will  be  unstable  and  will  undergo  distortion  to  form  a  system  of  lower 
symmetry and lower energy, thereby removing the degeneracy [Housecroft 2005].  
 
 
Figure 1.2: the changes in the energies of the electrons occupying the d orbitals of an M
n+ ion 
when the latter is in an octahedral crystal field. The energy changes are shown in terms of the 
orbital energies [Housecroft 2005]. 
 
From the Oh character table, it can be deduced that the dz2 and dx2−y2 orbitals have eg 
symmetry,  while  the  dxy,  dyz  and  dxz  orbitals  posses  t2g  symmetry.  The  energy 
separation between them is ∆oct. The magnitude of ∆oct is determined by the strength 
of the crystal field, the two extremes being called weak field and strong field. 
Octahedral  complexes  of  d
9  ions  are  often  distorted,  e.g.  CuF2  (the  solid  state 
structure of which contains octahedrally sited Cu
2+ centres), so that two metal-ligand 
bonds  (axial)  have  different  lengths  with  respect  to  the  remaining  four  bonds 
(equatorial). This is shown in Figure 1.3 (a) (elongated octahedron) and in Figure 1.3 
(b) (compressed octahedron).  
 
 
Figure 1.3: effect of Jahn-Teller distortion  
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For a d
9 configuration the two orbitals in the eg set are occupied by one and two 
electrons  respectively.  If  the  doubly  occupied  orbital  is  in  the  dz2  ,  most  of  the 
electron density in this orbital will be concentrated between the cation and the two 
ligands on the z axis. Thus, there will be greater electrostatic repulsion associated 
with these ligands than with the other four, and the complex will suffer elongation 
(Figure 1.3 (a)). Conversely, if the doubly occupied orbital is in the dx2−y2, it would 
lead to elongation along the x and y axes (Figure 1.3 (b)). The corresponding effect 
when the t2g set is unequally occupied is expected to be much smaller since the 
orbitals are not pointing directly at the ligands. Distortions of this kind are called 
Jahn–Teller distortions. 
1.3.2  Copper speciation in aqueous solutions 
The +3 oxidation state is known in solids such as Cu2O3, but such compounds are 
powerful oxidizing in water and are not stable. The speciation data for copper regard 
therefore only the oxidation states (I) and (II). However, the equilibrium constant for 
the Cu
+ disproportionation reaction in water, according to (1.4), 
 
2Cu
+    ⇌    Cu
2+ +  Cu
0            (1.4) 
 
is 10
6, and therefore only small amounts of Cu
+ can exist in water if this ion is not 
stabilized.  
Cupric ion with its d
9 configuration has a ligand field stabilization in its complexes, 
and  usually  the  Jahn-Teller  effect  is  observed.  This  causes  the  hydrated  ion 
Cu(H2O)6
2+  to  have  a  distorted  octahedral  structure  with  weak  absorption  in  the 
visible [Cotton 1968]. Two of the water molecules in trans position are more distant 
from the Cu
2+ ion than the other four, which are coplanar. The Cu
2+ ion is stable at 
acidic  pH.  Above  pH  4  it  begins  to  hydrolize,  and  it  precipitates  as  oxide  or 
hydroxide soon thereafter. The formation constants of copper hydroxo-complexes 
estimated in 3 M perchlorate media at 25°C are shown in Table 1.7.  
 
Table 1.7: formation constants of copper hydrolysis products, and solubility product of the most 
important copper oxide [Charles 1976]. Constants refer to the equilibrium  
mCu + nH2O ⇌ Cum(OH)n + nH
+ 
Species  Log β 
CuOH
+  < −8 
Cu(OH)2  < −17.3 
Cu(OH)3
−  < −27.8  
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Cu(OH)4
2−  −39.6 
Cu2(OH)2
2+  −10.36 
CuO(s)  pKs=7.62 
 
The only important hydrolysis product of Cu
2+ is CuO, which is insoluble enough to 
limit the concentration of Cu
2+ which can exist in solution as the pH is increased. 
Cu
2+ hydrolyzes only to a slight extent at moderate concentrations (~10
−3m) before 
precipitation occurs. The principal hydrolysis product is the dimer Cu2(OH)2
2+. A 
series of mononuclear species, from CuOH
+ to Cu(OH)4
2−, are formed as well. The 
first three should be important only in very diluted solutions between pH 8 and 12, 
and the last forms only in very alkaline solutions. In spite of several estimates, the 
stability of CuOH
+ is only approximately known. Presently, it can be said that its 
logβ is less than −8. As well, the stabilities of Cu(OH)2 and Cu(OH)3
− are reported 
but are also not precisely known. The reason is that this species coexist at very low 
concentration with the solid. On the other hand, the stability of Cu(OH)4
2− is fairly 
well established by measurements of the solubility of CuO in basic solutions. 
1.3.3  Complex  formation  between  copper(II)  and  ligands:  structural  and 
thermodynamic aspects 
A very large number of Cu
2+ complexes are known. Cupric copper forms neutral, 
anionic and cationic complexes both of non-chelate and chelate kind. Complexes 
containing N- and O-donor ligands are very common, and coordination numbers of 
4,  5  and  6  predominate.  For  example  both  the  aqua  species  [Cu(H2O)6]
2+  and 
[Cu(H2O)4]
2+  exist.  The  most  common  coordination  geometry  is  the  distorted 
octahedral,  but  the  square  pyramidal,  the  trigonal-bipyramidal,  and  the  distorted 
tetrahedral, are sometimes observed. Since the electron population of the Cu
2+ ion is 
d
9, in any complex with regular octahedral symmetry the Jahn-Teller effect decreases 
the energy of the dz2 orbital. It is therefore occupied by two electrons (while the 
dx2−y2 orbital is occupied by one), and the approach of a nucleophilic ligand on the z 
axis  is  inhibited  by  the  presence  of  a  higher  electron  density.  Consequently  the 
distances Cu-L along the z axis are greater than the four Cu-L distances in the xy 
plane.  In  the  limit,  a  square  planar  complex  can  be  derived  from  an  octahedral 
complex by the removal of two ligands on the z axis. 
Among the ligands, the major copper binder contain oxygen atoms, or oxygen atoms 
and  nitrogen  atoms.  In  relatively  few  complexes  the  binding  is  assured  by  only 
nitrogen atoms, as in the very stable [Cu en2]SO4, and in even fewer cases by sulphur 
atoms.   
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Copper can form many neutral dichelate complexes with β-diketones and similar 
compounds. They are insoluble in water, but soluble in organic solvents including 
hydrocarbons. Other neutral poorly soluble complexes are formed by aminoacids. 
The  Cu
2+-glycine  (H2NCH2COOH)  complex  is  deep  violet-blue.  Cupric 
disalicyldioxime is also very insoluble. 
Negatively  charged  complexes  are  formed  e.g.  by  carbonate  and  oxalate:  their 
sodium salts, e.g. Na2[Cu(C2O4)2]·2H2O, have been isolated. 
Positively charged complexes, on the other hand, are commonly formed when Cu
2+ 
coordinates to amines, as e.g. forming the dichelate and trichelate ethylenediamine 
derivative [Durrant 1970]. 
1.3.4  Complex formation between copper(II) and ligands: kinetic aspects 
As seen, the six water molecules are arranged around Cu(II) ion in a tetragonally 
distorted octahedron [Hunt 1983]. Water substitution can easily occur at the very 
labile axial positions. Rapid inversion of the axial and equatorial ligands leads then 
to apparent easy substitution in the equatorial position [Eigen 1963]. The resulting 
water  exchange  speed  is  so  rapid  (k  =  10
10  s
−1)  that  for  example  it  cannot  be 
determined  accurately by 
17O NMR  [Hunt 1983]. The Cu(II)-methanol  system  is 
more  amenable  to  study.  The  mean  lifetime  at  25  °C  of  a  particular  tetragonal 
distortion in Cu(MeOH)6
2+ is 12·10
−11 s while that for CH3OH is 1.4·10
−8 s; thus the 
six coordinated methanols are indistinguishable. From thermodynamic data and from 
a comparison of CH3OH exchange with M(CH3OH)6
2+, M = Mn
2+, Fe
2+, Co
2+, Ni
2+ 
and Cu
2+, it is concluded that electronic occupancy of d-orbitals and effective radius 
dictates  the  dissociative  mode  (D).  This  means  that  the  mechanism  involves  an 
intermediate having a lower coordination number than in the reactant, as explained in 
the scheme (1.5): 
 
Cu(H2O)n   ⇌    Cu(H2O)n−1 + H2O  k1,  k−1 
                    (1.5) 
Cu(H2O)n−1 + L   ⇌    Cu(H2O)n−1L  k2,  k−2 
 
The  speed  of  substitution  of  the  solvent  from  the  metal  depends  also  on  the 
concentration and the type of the ligand. If the concentration of L is low, k2[L] < 
k−1[H2O] so that M is scavenged by H2O preferentially; otherwise M is scavenged by 
both L and H2O, or preferentially by L. 
Furthermore, ligand exchange reaction has been studied. When the Cu complex has 
one or more coordinated water e.g. in reaction (1.6) 
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                                                    k 
CuL(H2O)m
(2−n)+ + cyclamH
+    →   Cu(cyclam)
2+ + H
+ + L
n− + mH2O  (1.6) 
 
The following relationship of logk with logKCuL (1.7) is followed: 
 
                         
                   (1.7) 
 
with k0 = 1.1·10
7 M
−1 s
−1 and K0 = 2.3·10
10 M
−1 at 25 °C and I = 1.0 M (KNO3). This 
means that for the weaker Cu
2+ complexes (logKCuL < 10.4), k is independent on the 
nature  of  L,  and  unwrapping  of  the  coordinated  L  is  not  a  prerequisite  for 
interchange. For very stable Cu complexes (logKCuL >> 10.4), there is an inverse 
relationship  between  the  stability  of  CuL  and  its  reactivity  in  ligand  exchange 
reactions [Wilkins 2002]. 
1.3.5  Biochemistry and toxicity of copper 
The essentiality of this element is known since the 1930s, when the need of copper in 
the production of heme A, a component of cytochromeoxidase, was demonstrated 
[Cohen 1934]. Subsequent studies have shown that this element  is an essential trace 
metal used as a catalytic cofactor for many enzymes. 
Homeostasis of metal ions is critical for life and is maintained within strict limits 
[Bertini 2008]. In particular, redox active metals likely play a major role in altered 
redox balance. For example, superoxide dismutase is an enzyme that contains copper 
and has antioxidant capacity against the formation of superoxide radicals [Wilson 
1987]: this enzyme is inhibited by low levels of the element, but on the other hand an 
excess  of  copper  ions  catalyses  the  formation  of  free  radicals  [Floyd  1933],  by 
undergoing redox cycling and causing oxidative stress by increasing the formation of 
reactive oxygen species (ROS) like superoxide ion, hydrogen peroxide, and hydroxyl 
radical. This will eventually result in the damage of many biomolecules in the cells 
[Arnal 2012]. Copper ions in vivo exist in Cu
+ and Cu
2+ oxidation states and can 
undergo electron transfer reactions in living system. In the reductive environment of 
the cell, Cu
2+ can be reduced to Cu
+ by ascorbate or glutathione, and the reduced Cu
+ 
can be oxidised to Cu
2+ through the Fenton reaction. The reduced metal ion Cu
+ 
generates  extremely  reactive  hydroxyl  radicals  from  hydrogen  peroxide  like  in 
reaction (1.8) [Suzuki 1981]. 
 
Cu
+ + H2O2   →   Cu
2+ + OH
 + OH
–           (1.8) 
 
Some scientists believe that environmental factors are responsible for the increased 
copper uptake. The metal ion might be more bioavailable because it is leached from 
copper plumbing in  homes  or  ingested  as  inorganic copper from  vitamin/mineral  
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supplements. Cu overload is implicated in the pathogenesis of a variety of human 
diseases like cancer, cirrhosis, atherogenesis and neurodegenerative diseases [Arnal 
2012]. 
On  the  other  side,  copper  deficiency  is  associated  with  anaemia,  osteoporosis, 
abnormal pigmentation of the skin (as experimentally tested on animals), whereas 
some human diseases, such as Wilson's disease and some forms of cirrhosis, are 
related to an alteration of copper metabolism. The total content in the human body is 
normally between 80 and 120 mg. About 1/3 of this quantity is in liver and brain, 
while another third is located in the skeleton. The normal level in the plasma, where 
almost all copper (90-95% of it) is bound to ceruloplasmin is approximately 1 mg/L. 
Copper assumed with the diet is absorbed in the duodenum to an extent of about 
30%.  The  daily  requirement  is  1.5-3  mg.  Generally,  a  balanced  diet  provides 
adequate  amounts  of  copper.  Deficiencies  have  been  observed  in  malnourished 
children and may occur in patients who undergo parenteral nutrition for a long time.  
 
1.4  ALZHEIMER’S DISEASE 
Alzheimer’s disease (AD) is the most common cause of progressive dementia in the 
elderly  population.  It  is  a  chronic  neuro-degenerative  disorder  that  leads  to 
progressive  disturbances  of  cognitive  functions  including  memory,  judgement, 
decision-making,  orientation  to  physical  surroundings  and  language  [Nussbaum 
2003]. The disease has no doubt existed for millennia, but it was often confused with 
other  syndromes  that  also  presented  as  “senile  dementia”,  that  is,  progressive 
cognitive  decline  after  middle  age.  The  description  of  the  clinic-pathological 
syndrome  by  the  Bavarian  psychiatrist,  Alois  Alzheimer,  in  1906  established  a 
neuropathological  phenotype  that  has  enabled  considerable  diagnostic  specificity, 
although until recently only at the end of the patient’s life.  
Progress in elucidating the biology of AD first arose from the compositional analyses 
of amyloid plaques and neurofibrillary tangles in the mid-1980s.  
Alzheimer’s disease (AD) is characterized by innumerable deposits of extracellular 
amyloid plaques. A small peptide, amyloid-β peptide (Aβ), plays a critical role in the 
initial build up of these amyloid plaques and is the main constituent of the amyloidal 
deposits [Masters 1985]. Amyloid-β peptide can be between 39 and 43 residues in 
length, of which Aβ-(1-40) and Aβ-(1-42) are the most abundant fragments. Aβ42 is 
more prone to aggregation and more toxic to neurons than Aβ40. The β-amyloid 
peptides can react together to form soluble oligomers, protofibrils, fibrils or insoluble 
extracellular aggregates. In particular, soluble oligomers appear to be responsible for 
the  toxicological  mechanisms,  as  they  can  directly  damage  neurons  by  oxidative  
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attacks;  they  are  involved  also  in  the  alteration  of  electrochemical  signals,  for 
example by creating small membrane channels that unbalance the ionic gradients of 
Ca
2+. 
Neurofibrillary tangles are generally intraneuronal cytoplasmic bundles of paired, 
helically wound ~10 nm filaments (PHFs), often interspersed with straight ~10 nm 
filaments [Geser 2008]. Neurofibrillary tangles usually occur in large numbers in AD 
brains,  particularly  in  entorhinal  cortex,  hippocampal  formation,  amygdala, 
association cortices of the frontal, temporal and parietal lobes, and certain subcortical 
nuclei that communicate with these regions. The subunit protein of the PHF is the 
microtubule-associated  protein,  tau.  This  plays  a  central  role  in  maintaining  the 
structural integrity of neuronal microtubules, that are polymers of tubulin that form 
the cytoskeleton. 
The two classical proteinaceous lesions of AD can occur independently in humans. 
There  are  some  cases  of  AD  itself  that  are  “tangle-poor”,  that  is,  very  few 
neurofibrillary tangles are found in the neocortex together with abundant Aβ plaques 
[Terry 1987]. The main risk factors for AD include exogenous factors, like brain 
trauma, smoking, obesity, diabetes, hypertension, hypercholesterolemia, exogenous 
exposure to metals (especially Pb, Hg, and Al). Estimates of the proportion of AD 
cases that are genetically based have varied widely from as low as 10% to as high as 
40% or 50%, and some investigators believe that, in the fullness of time, virtually all 
cases will be shown to have some genetic determinants. 
1.4.1  Effects of Zn
2+, Cu
2+ and Al
3+ associated with Alzheimer’s disease 
Some metal ions appear to have a role in the disease. Analysis of the autopsy of AD 
patients shows abnormally high levels of specific metal ions in the senile plaques 
(Cu
2+, 25 μg/g, ~393 μM; Zn
2+, 69 μg/g, ~1055 μM). Al
3+ has also been detected in 
amyloid fibers in cores of the senile plaques [Yumoto 2009]. These metal ions are 
Lewis  acids,  and  for  this  reason  they  are  able  to  coordinate  Aβ,  thanks  to  the 
interaction with nitrogen and oxygen atoms, Lewis bases, belonging to the amino 
acid residues situated in the portion of amyloid peptide 1-16, with the formation of 
complexes with the stoichiometric ratio of 1:1. The complex formation is supposed 
to  lead  to  stabilization  and/or  induction  of  β-amyloid  oligomers  formation.  An 
independent support of this metal ion role comes from the experimentally evidence 
that the imbalance of cellular Zn
2+ and/or Cu
2+ homeostasis modulates AD pathology 
[Zatta 2009], and dietary Cu
2+ and Al
3+ are risk factors for AD [Frisardi 2010]. Zn
2+ 
and Cu
2+ have been shown to accelerate Aβ deposition in vivo forming amorphous 
aggregates [Bush 1994], even if Zn
2+ affinity for Aβ is significantly weaker than that 
of Cu
2+. Al
3+ promotes Aβ fibrils or oligomer formation [Zatta 2009].   
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On the other side, Cu
2+ and Zn
2+ are essential cofactors for the activity of many α-
secretase and some protease involved in the cleavage of β-amyloid in small peptides. 
It is clear, therefore, that a defect of these metals in the body lead to accumulation of 
amyloid  peptides.  Several  attempts  were  made  to  obtain  efficient  chelators  with 
moderate  affinity  towards  copper  and  zinc  that  participate  to  the  amyloid 
aggregation, in order to prevent the formation of plaques [Kozlowski 2012]. 
As  mentioned  above,  copper  takes  part  in  the  Fenton  reaction,  according  to  the 
reaction  (1.8).  A  healthy  organism  can  ensure  a  homeostasis  condition  between 
production and elimination of ROS. Thanks to the enzymes proposed to antioxidant 
defense, the organism can eliminate these radical species. Two categories of enzymes 
have  been  mentioned,  belonging  to  the  family  of  oxidoreduttase: 
superoxidodismutase (SOD) and catalase; they act according to the reactions (1.9) 
and (1.10) respectively. 
 
2 O2
• – + 2 H
+   ⇌   O2 + H2O2  (1.9) 
2 H2O2   ⇌   O2 + 2 H2O  (1.10) 
 
Other radicals, known to be harmful to the body, are the RNS (Reactive Nitrogen 
Species). RNS derive from the nitric oxide radical (NO •), produced by the nitric 
oxide synthase (NOS) enzyme. This radical is an important cellular messenger and 
plays a key role in the body's immune system of a healthy organism. However, the 
reaction (1.11) takes place in the presence of a superoxide anion radical, leading to a 
very  reactive  species,  peroxynitrite  (ONOO
−).  This  is  responsible  for  the 
nitrosylation  of  proteins,  DNA  and  mitochondrial  metabolism  damage,  and  for  a 
series of  reactions that are known as condition of nitrosative stress. 
 
NO + O2
 −   →   ONOO
−  (1.11) 
 
Oxidative stress seems to be one of the main causes of Alzheimer's disease, because 
the  mitochondrial  functionality  related  to  it,  gradually  decreases  with  age.  The 
central role of metals in the pathogenesis of the disease can derive from an imbalance 
between free ions and ions bound to enzymes. More precisely, if the pool of free 
metals prevails over that of bound metals, the condition of oxidative stress is much 
more favored: on one side, an accumulation of ROS and RNS thanks to the Fenton 
reaction is observed, on the other hand  a deficit of detoxification mechanisms is 
verified, due to the lack of metal cofactors in the reactive sites of SOD and catalase. 
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2  CHELATION THERAPY 
 
 
2.1  INTRODUCTION 
The only therapy that has been proven to be effective in the treatment of acute and 
chronic  intoxications  due  to  excessive  absorption  of  metal  ions  is  based  on  the 
administration  of  chelating  agents  able  to  selectively  complex  the  metal.  This 
therapeutic approach is named chelation therapy, and is currently employed for the 
detoxification of several metals. The objective of chelation therapy is the removal of 
toxic metal ions from human body or attenuation of their toxicity by transforming 
them into less toxic compound or dislocating them from the site at which they exert a 
toxic action [Crisponi 2012 (b)].  
An  ideal  chelating  agent  should  have  some  specific  requisites,  that  can  be 
summarized as follows: 
 
  Selectivity toward the target metal ion and not towards other essential ions; 
  Stability  of  the  complexes,  i.e.  higher  stability  constants  than  those  with 
endogenous ligands; 
  Fast kinetic exchange of the toxic metal ion between chelator and endogenous 
ligands; 
  Lack of toxicity both of the chelating agent and of its complexes; 
  The chelating agent, once in the body, should not promote redox reaction like 
the Fenton (1.8); 
  Good oral absorbability and intestinal absorption and good bioavailability to 
the target cells; 
  Slow rate of metabolism, to permit the complete formation of the complexes 
before their excretion; 
  Favorable excretion of the complexes formed;  
  Low production costs. 
 
Selectivity  and  stability  of  a  chelator  in  vivo  can  be  estimated  if  the  stability 
constants of the metal-chelator complexes are known. As the complex formation is a 
competitive reaction between proton and metal ion for the same basic sites of the 
ligand, a more general parameter, different than the stability constants, is needed to  
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compare the selectivity and stability of different chelators. This parameter can be the 
pM. It is defined as –log[M] at [M]Tot = 1·10
–6 molL
−1 and [L]Tot = 1·10
–5 molL
−1 at 
pH 7.4, where [M] is the  concentration of the free metal ion and [M]Tot and [L]Tot are 
the  total  concentrations  of  metal  and  ligand,  respectively.  pM  values  are  key 
parameters in order to chemically evaluate a chelator. 
It is well known that any toxic metal chelating agent can complex and therefore 
remove from body also essential metal ions, thus causing toxic side effects due to 
metal ion deficiency. Copper, and especially zinc, appear to be the most affected 
essential  metal  ions  during  the  chelation  therapy  regiments;  for  example,  zinc 
deficiency  problems  are  sometimes  experienced  in  the  Deferiprone  therapy  of 
aluminium and iron overload pathologies [Kontoghiorghes 1995]. On one side, the 
evaluation of the complexation strength of a chelator towards Cu
2+ and Zn
2+ can 
allow  to  predict  the  extent  of  essential  metal  ion  removal  during  the  chelation 
therapy. On the other hand, several studies have been carried out in order to find 
efficient chelators with moderate affinity towards metal ions such as Cu
2+ and Zn
2+, 
that  cause  toxic  effects  if  present  in  high  levels  in  the  organism,  and  that  may 
participate of the amyloid aggregation [Kozlowski 2012] within Alzheimer disease. 
Therefore, the Cu(II) and Zn(II) complex formation of a chelator should always be 
known. 
Another key requirement of a chelator is the oral absorbability, because it would 
allow the best comfort for the patient, and lower health care therapy costs, compared 
to  any  other  way  of  administration.  Lipinski  has  listed  the  requirements  that  a 
molecule must possess in order to be bioavailable in the gut [Lipinski 1997]: 
 
1.  Molecular mass lower than 500 Dalton; 
2.  LogP < 5, where P is the n-octanol/water partition coefficient. The value of 
logP indicates how much the molecule is lipophilic; 
3.  Presence of less than 10 hydrogen bond donors; 
4.  Presence of less than 10 hydrogen bond acceptors. 
 
Although the " Lipinski rules" are generally valid, it should be noticed that one of 
them, the requirement of lipophilicity, is controversial. It is essential that the chelator 
has an appropriate lipophilicity, in order to be able to cross the cellular membranes, 
but at the same time, it requires a certain degree of hydrophilicity, in order to be 
transported in plasma.  
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2.1.1  Metal coordination number in metal complexes 
The  metal  coordination  number  (CN)  is  very  important  for  the  determination  of 
structure and properties of metal complexes with chelating agents. As seen in chapter 
1, the preferred CN for several metal cations is ambiguous (e.g., for both Cu
2+ and 
Zn
2+ CN=4, 5, or 6 [Rotzinger 2005, Dudev 2000]), and the factors determining the 
metal CN are often not fully understood. The CN depends on (1) metal size, charge, 
charge-accepting  ability  and  (2)  ligand  size,  charge,  charge-donating  ability, 
denticity (number of  coordinating groups which can bind the metal ion at the same 
time) [Dudev 2006]. 
The metal size plays a role in determining the CN. The CN in hydrated complexes 
often increases by increasing the size of the metal, even if with many exceptions. 
Metal charge and charge-accepting ability do not seem to be the major determinants 
of the metal CN in complexes containing neutral ligands such as water. Al
3+, Cu
2+ 
and Zn
2+ are in fact all hexacoordinated in water, despite their difference charges and 
charge-accepting abilities. 
Ligand net charge and charge-donating ability, rather than the ligand size, have an 
important role in determining the metal CN. For example, when two water molecules 
are replaced by two negatively charged monodentate ligands such as Cl
− or Br
−, the 
CN of Cu
2+ and Zn
2+ is lowered from 6 to 4. Negatively charged ligands, which are 
good  charge  donors,  affect  the  metal  CN  more  than  neutral  ligands.  Also  the 
denticity of a ligand plays an important role in determining the CN of the metal. 
Denticity  also  significantly  affects  the  metal-ligand  complexation  strength.  At 
constant metal-ligand bond strength, the stability of complexes formed is maximum 
for  hexadentate  chelating  agents,  due  to  the  greater  entropy  resulting  from  the 
complexation reaction (2.1): 
 
M(H2O)6 + 3 LB   ⇌   M(LB)3 + 6 H2O 
M(H2O)6 + 2 LT   ⇌  M(LT)2 + 6 H2O  (2.1) 
M(H2O)6 + LE   ⇌  MLE + 6 H2O 
 
(LB is a bidentate ligand, LT is a tridentate and LE is a hexadentate one).  
As  another  disadvantage  of  the  bidentate  and  tridentate  ligands,  they  can  form 
multiple complexes  in  vivo, whose concentration depends  on total  ligand and on 
metal-to-ligand ratio, thus complicating the speciation model. On the other hand, 
bidentate  and  tridentate  ligands  have  an  important  advantage  over  hexadentate 
ligands,  because  they  can  be  orally  more  active  thanks  to  their  lower  molecular  
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weight. Furthermore, chelating molecules with molecular mass lower than 300 Da 
can also cross the membrane of the brain [Gaeta 2005].  
 
2.2  CHELATING DRUGS FOR IRON AND ALUMINIUM INTOXICATIONS 
Aluminium and iron are currently the most important among the different metal ions 
involved in chelation therapy, due to the relatively high occurrence of their overload-
produced  diseases.  Chelators  used  for  iron  can  be  used  for  aluminium,  and  vice 
versa, because of the very similar coordination chemistry which is displayed by the 
two hard M
3+ ions. 
Chelating drugs  existing for  aluminium  and iron  overload  are Deferoxamine and 
Deferiprone. Exjade is a new drug which presently is used for iron chelating therapy 
only, but it can in principle be proposed also for aluminium. 
Deferoxamine (DFO) (Figure 2.1(a)) is a tris-hydroxamic derivative produced by the 
bacterium Streptomyces pilosus as growth agent [Keberle 1964]. It was introduced in 
1970 in iron intoxication's therapy and, some years later, the use has been extended 
in the aluminium chelation therapy. DFO is an hexadentate ligand which forms very 
stable  1:1  complexes  with Al
3+  and  Fe
3+.  Six  oxygen  atoms  are  involved  in  the 
coordination (three pairs of O-N-C=O), forming with the metal three chelated rings 
with five terms each. DFO has several disadvantages. Firstly, its complexes have a 
low lipophilicity which inhibits the penetration in human cells thus allowing the only 
chelation of blood iron. Furthermore, DFO has a high molecular mass (> 500 Da), 
that prevents its oral intake, and it is rapidly metabolized towards non-complexing 
derivatives.  For  this  reasons,  very  slow  subcutaneous  infusions  of  the  drug  are 
necessary (from 8 to 12 hours), for five up to seven times per week, compromising 
the life of the patient. Moreover it was observed that since DFO forms more stable 
complexes with iron than with aluminium, patients taking this drug for aluminium 
intoxications may undergo iron deficiency. Finally, there are important side effects of 
this  chelator,  such  as  abnormalities  in  the  eye  (cataracts),  growth  delay,  sleep 
disorders,  allergies,  anaphylactic  reactions,  as  well  as  renal  and  pulmonary 
complications. 
Deferiprone  (L1)  has  been  proposed  as  alternative  drug  in  order  to  overcome 
problems related to the DFO therapy. It is a bidentate ligand able to form strong 
complexes with stoichiometric metal-to-ligand ratio 1:3 (at physiological pH) both 
with Fe
3+ and Al
3+ (Figure 2.1(b)). Thanks to its low molecular mass, L1 can be 
orally administrated, two or three times per day. Moreover, L1 affinity for aluminium 
is only slightly lower than that of DFO. However, the chelator causes several side 
effects such as gastrointestinal complications, skeletal pains and zinc deficiency. The  
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latter is a consequence of the ability of L1 to complex also zinc(II) [Kontoghiorghes 
2000].  Another  disadvantage  of  L1  is  its  rapid  hepatic  metabolism,  due  to  the 
conjugation of the hydroxyl group in the ring position 3 with glucuronide, and the 
resulting loss of its chelation ability. This forces the administration of high doses of 
the drug, thus causing more severe toxic side effects. Despite these drawbacks, the 
therapeutic use of L1 is licensed in India since 1995 and in Europe since 2000, where 
it  is  still  administered  in  patients  who  have  experienced  allergic  or  toxic  effects 
towards DFO.  
Exjade (ICL670, Figure 2.1(c)) and some of its triazole derivatives have received 
considerable  attention  in  recent  years  [Lattmann  1997].  ICL670  has  two  oxygen 
atoms and one nitrogen atom acting as charge donors, therefore it is considered a 
tridentate ligand. Currently, it is only used for iron chelation therapy. ICL670 has a 
good oral bioavailability but, because of its high hydrophobicity, it is able to cross 
membranes  easily,  inducing  the  redistribution  of  toxic  metals  in  the  tissues. 
Furthermore, the presence of a nitrogen atom between the chelating groups, probably 
promotes the complexation of other essential metals [Liu 2002]. This disadvantage is 
typical of tridentate ligands, which contain always at least one nitrogen donor atom 
having larger affinity towards essential metal ions. 
Besides DFO; L1 and ICL670, there is a number of other ligands which have been 
proposed, or are currently under study, for the chelation therapy of aluminium and 
iron. Next paragraphs lists some of these compounds. 
 
 
 
Figure 2.1: (a) Deferoxamine (DFO), (b) Deferiprone (L1), (c) Exjade (ICL670) 
 
2.2.1  Bisphosphonates derivatives 
Bisphosphonates (Table 2.1) have long been studied to investigate their chelating 
properties towards iron and aluminium. It was established that they form extremely 
stable complexes, even more stable than those formed by L1. They also have a good 
toxicity profile and their low molecular weight enables good intestinal adsorption. 
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Table 2.1: 1-Phenyl-1-hydroxymethylene bisphosphonate and three derivatives [Crisponi 2012 
(b)] 
Formula  Full name 
 
1-Phenyl-1-
hydroxymethylene-1,1 
bisphonic acid 
 
[1-(Diethoxyphosphinyl)-1-
hydroxybenzyl]-1- 
phosphonic acid 
 
1-Benzyl-1-
hydroxymethylene-1,1- 
bisphosphonic acid 
 
1-Hydroxyethane-1,1-
bisphosphonic acid 
 
Other  two  families  of  derivatives  were  synthesized  (Table  2.2),  in  which  the 
bisphosphonate units are connected to a catechol or pyridinone unit; both of them in 
fact are strong iron and aluminium chelators.  
 
Table 2.2: catechol and hydroxypyridinonate-bisphosphonate derivatives [Crisponi 2012 (b)] 
Formula  Full name 
 
3,4-Dihydroxy phenyl 
ethylidene bisphosphonic 
acid 
 
2,3,4-Trihydroxy phenyl 
ethylidene bisphosphonic 
acid 
 
1-(3,4-Dihydroxybenzyl)-1-
phenyl methylene 
bisphosphonic acid  
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2,3-Dihydroxy phenyl 
ethenylidene bisphosphonic 
acid 
 
3,4-Dihydroxy phenyl 
butylidene bisphosphonic 
acid 
 
1-(3,4-Dihydroxybenzyl)-1-
ethyl methylene 
bisphosphonic acid 
 
2,3-Dihydroxy phenyl 
ethylidene 
bisphosphonic acid 
 
3-([(1-Hydroxy-6-oxo-1,6-
dihydro-2- 
pyridinyl) carbonyl]amino-1- 
phosphonopropylphosphonic 
acid 
 
2.2.2  Kojic acid derivatives  
Kojic  acid  (5-hydroxy-2-(hydroxymethyl)-4-pyrone)  is  a  natural  derivative  of  4-
pyrone, produced by some species of mould. Kojic acid and its derivatives (Table 
2.3) are good chelating agents for hard metal ions such as Fe
3+ and Al
3+.  
 
Table 2.3: chemical structure of kojic acid derivatives [Crisponi 2012 (b)] 
Formula  Full name 
 
5-Hydroxy-2-hydroxymethyl-
pyran-4-one 
 
6-[5-Hydroxy-2-
hydroxymethyl-pyran-4-one]-
5-hydroxy-2-hydroxymethyl-
pyran-4-one  
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2,2’−[(2-Hydroxy-3-
methoxyphenyl)methanediyl] 
bis[3-hydroxy-6-(hydroxyl 
methyl)-4H-pyran-4-one] 
 
2,2’−[(4-Hydroxy-3-
methoxyphenyl) 
methanediyl]bis[3-hydroxy-
6-(hydroxyl methyl)-4H-
pyran-4-one] 
 
Several studies have shown that both Kojic acid and its dimer are able to bind Al
3+, 
forming very stable mono and binuclear species, variously protonated. The study of 
these chelators is still in progress, with the aim to determine their behavior towards 
essential metal ions such as Cu
2+, Zn
2+, Ca
2+, and Mg
2+.  
2.2.3  Hydroxypyridinecarboxylic acids  
In recent years, the studies conducted by the research group in which this thesis work 
is  included,  focused  on  a  new  class  of  compounds  for  Fe
3+  and  Al
3+  chelation 
therapy:  hydroxypyridinecarboxylic  acids  (HPCs).  The  HPCs  state  of  art  is 
summarized in a recent review paper [Crisponi 2012 (b)]. 
The two simplest unsubstituted derivatives are 3–hydroxy–4–pyridinecarboxylic acid 
(DT0) and 4–hydroxy–3–pyridinecarboxylic acid (DQ0) shown in Figure 2.2 (a) and 
Figure 2.2 (b) respectively. Ring substitution of DT0 and DQ0 gives the DTs and 
DQs  derivatives,  respectively.  DTs  and  DQs  possess  two  oxygenated  ortho 
functional  groups,  the  carboxylic  acid  (–COOH)  and  the  phenol  (–OH).  As  they 
behave as Lewis hard bases, in their deprotonated forms they are capable to bind  
metal ions of the same type, forming a strong six-membered metal chelation ring. 
The  pyridine  nitrogen  has  a  significant  effect  in  enhancing  the  metal  ion 
complexation strength compared with hydroxybenzenecarboxylic acids (i.e. salicylic 
acid  derivatives)  because  of  the  strong  electron-attracting  effect  of  the  charged 
pyridinic-N
+.  This  effect  has  been  experimentally  proven  by  comparing  the  pKA 
value of –OH in DTs without a N-methyl substituent with those in N-substituted 
DTs: it has been observed that for the latter pKA is much lower (pKA ~ 11 for N-
unsubstitued DTs, pKA ~ 7 for N-methyl derivatives).  
 
33 
 
 
Figure 2.2: (a) 3–hydroxy–4–pyridinecarboxylic; (b) (DT0) and  4–hydroxy–3–
pyridinecarboxylic acid (DQ0). 
 
HPCs  have  several  advantages  with  respect  to  the  other  existing  or  proposed 
aluminium and iron chelators. Above all, they have a low molecular mass, which 
should allow a good oral bioavailability, and they have very low toxicity in vitro. 
Toxicity in vivo is still unknown as no systematic work has been performed up to 
now; however, there is one important example, pyridoxic acid (POA), that allows to 
assume that HPCs are non-toxic in vivo, too. POA is a derivative of DT0 (so it is 
structurally very similar to the ligands examined) and it is a non-toxic metabolite of 
vitamin B6 . As another important advantage of HPCs over L1, the hydroxyl in POA 
(and presumably in all HPCs) does not undergo conjugation in vivo; here also more 
systematic studies are needed to confirm that the POA data can be generalized to all 
HPCs. HPCs studied so far have also expressed modest or low affinity for divalent 
essential ions in the organism, such as Zn
2+, Cu
2+ and Fe
2+. Therefore, HPCs should 
not interfere with the biochemistry of these metals [Dean 2009]. However, although 
the complexes formed with hard metal ions are very stable, DT0 and DQ0 affinity for 
Al
3+ and Fe
3+ is appreciably weaker than that generated by drugs currently in use, 
such as L1. For this reason several DT0 and DQ0 derivatives have been synthesized 
and studied, in  order to  increase the strength  of complexes  with  the  two metals, 
without  changing  the  other  positive  properties.  The  possibility  which  has  been 
hitherto studied was the insertion of methyl substituents on the free positions of the 
pyridine  ring,  i.e.  in  position  1,  2,  5,  and/or  6:  this  moderate  electron-donating 
functional  group was expected to increase the basicity of chelating oxygens and, 
therefore, to increase the complexing affinity towards hard metal ions. 
Table 2.4 shows the methyl derivatives of DT0 (DTs) and DQ0 (DQs) that have been 
synthesized and studied so far.  
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Table 2.4: hydroxypyrdinecarboxylic acids studied so far [Crisponi 2012 (b)], and abbreviations 
adopted. Compounds are shown in their neutral form. 
Formula  Full name  Abbreviation 
 
 
3–hydroxy–1–methyl–4–
pyridinecarboxylic acid 
 
DT1 
 
 
 
4–hydroxy–1–methyl–3– 
pyridinecarboxylic acid 
 
DQ1 
 
 
3– hydroxy–2–methyl–4– 
pyridinecarboxylic acid 
 
DT2 
 
 
4– hydroxy–2–methyl–3– 
pyridinecarboxylic acid 
 
DQ2 
 
 
4– hydroxy–5–methyl–3– 
pyridinecarboxylic acid 
 
DQ5 
 
 
4– hydroxy–6–methyl–3– 
pyridinecarboxylic acid 
 
DQ6 
 
 
1,2–dimethyl–3– hydroxy–4– 
pyridinecarboxylic acid 
 
DT712 
 
 
1,5–dimethyl–4– hydroxy–3– 
pyridinecarboxylic acid 
 
DQ715 
 
 
1,6–dimethyl–4– hydroxy–3– 
pyridinecarboxylic acid 
 
DQ716 
 
 
2,6–dimethyl–3– hydroxy–4– 
pyridinecarboxylic acid 
 
DT726 
N
+
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2,6–dimethyl–4– hydroxy–3– 
pyridinecarboxylic acid 
 
DQ726 
 
Studies of these new derivatives have highlighted positive kinetic, toxicological (in 
vitro), and electrochemical properties, which are similar to those of the two not-
substituted HPCs.  
The stability constant studies performed on the methyl derivatives allowed to draw 
some conclusions. First, the stability of DTs and DQs complexes with Fe
3+ is almost 
the  same.  Instead,  it  seems  that  DQs  form  more  stable  complexes  with  Al
3+ 
compared to DTs. Second, considering the behavior of each member of the DQs 
class, in relation to its interaction with Fe
3+, it has been observed that the effect of the 
electron-donating methyl substituent on the complex stability is maximum when the 
methyl  is  introduced  in  position  1,  by  a  N-substitution  on  the  pyridine  ring. 
Otherwise  it  is  appreciable  but  minor  when  the  methyl  is  in  positions  5  and  6. 
Furthermore, the effect of –CH3 is additive, since dimethylated derivatives (DQ715 
and DQ716) form stronger complexes than monomethylated ones (DQ1, DQ5 and 
DQ6).  On  the  contrary,  studies  concerning  the  stability  of  DQs-Al
3+  complexes 
showed a minimal methyl effect in position 1, and a higher one in positions 5 and 6. 
The  insertion  of  a  methyl  in  ortho  to  the  carboxylic  group  (DQ2)  has  instead 
generated a negative effect, i.e. a considerable decrease in the complexing strength. 
This can be explained by the steric hindrance of the methyl group, which prevent the 
co-planarity between the –COOH and the pyridine ring. Consequently, a distortion of 
the chelate ring occurs and, as a result, a decrease in the complex stability arises. For 
this reason, DQ2 is the weakest chelator among the HPCs examined so far, whereas 
DQ726 complexes are stronger than those formed by DQ2 but weaker than those of 
DQ6. 
Third, results obtained for DTs-Fe
3+ are very similar to those obtained for DQs-Fe
3+. 
In  particular,  DT712  forms  the  complexes  having  the  highest  stability  with  Fe
3+ 
among HPCs investigated so far. In DTs-Al
3+ complexes, the substitutions of the 
pyridine  ring  with  one  or  more  methyl  groups  do  not  increase  the  complexation 
strength with the metal. There is in fact no big difference among DT0, DT1, DT2 and 
DT712 ability in binding Al
3+. 
Although suitable methyl substitutions eventually enhanced the complex stability of 
HPC complexes, that the complexing strength of even the best HPC prepared so far 
does not reach that of L1: pAl and pFe values are always one or more orders of 
N
+
OH
COO-
H
C H3
C H3 
 
36 
 
magnitude lower than the corresponding values of L1. Therefore, a different strategy 
is needed to design HPCs that can form stronger Al(III) and Fe(III) complexes.  
2.2.4  Other proposed molecules 
Several  alternative  molecules  have  been  studied  for  a  possible  improvement  as 
chelating drugs. Their structures are shown in Figure 2.3. These molecules have been 
subjected to clinical trials, but in the most cases toxic effects and/or low efficiency 
has been stated, so that they have been abandoned  
Hydroxybenzilethylenediaminodiacetic acid (HBED) is an aminocarboxylic phenolic 
chelating agent which has a higher chelating efficiency for metal ions than DFO. 
However,  despite  its    low  molecular  mass,  the  drug  must  be  administered  by 
intramuscular injections because the oral administration is not efficient [Bergeron 
1993]. Some derivatives of HBED have been studied (in particular the monoethyl 
ester) as orally active prodrugs. Their advantage is the ability to easily cross the 
gastro-intestinal  membrane,  due  to  their  hydrophobicity.  After  the  enzymatic 
hydrolysis of the ester bond, they gain a pharmacological activity and an increased 
hydrophilicity. Therefore, the metal-ligand complex just formed is easily removed 
and poorly permeate into cell membranes, so that the redistribution of the toxic ion in 
tissues is limited. The biggest disadvantage of HBED and of its derivatives is that 
their complexes with metals are toxic. Moreover, the presence of two nitrogen atoms 
in this ligands class is responsible for the strong coordination of essential metal ions. 
Desferrithiocin (DFT) is a tridentate ligand able to form strong complexes with Fe
3+ 
and Al
3+ [Hahn 1990]. The presence of the nitrogen atom favors also the formation of 
complexes with essential metals [Anderegg 1990]. Furthermore, DFT has several 
side effects, including neurotoxicity, nephrotoxicity and loss of body weight [Wolfe 
1990]. 
Pyridoxal isonicotinoyl hydrazone (PIH) is a tridentate ligand with strong affinity 
towards Al
3+ and Fe
3+, but it has an excessively slow kinetic of complexation. For 
this reason other derivatives have been studied which, however, are more toxic than 
the starting compound [Edward 1995]. 
Other interesting molecules investigated are some derivatives of L1. The insertion of 
substituents on L1 was tested in order to optimize its chelating properties and reduce 
adverse  effects  and  the  kinetic  of  degradation  in  vivo.  Among  these  derivatives 
CP502 is the most important one. It has an amide group in position 2 and a methyl in 
position 6 of the pyridine ring. This molecule is able to complex Fe
3+ with a stability 
about  hundred  times  higher  than  L1  at  physiological  pH  [Liu  2002].  A  similar 
positive effect in chelating the metal has been obtained with the introduction of a 
hydroxyalkyl  group  (for  example  −CH2OH)  in  position  2.  The  effect  of  both  
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substituents (amide and hydroxyalkyl) in position 2 leads to a decrease of the affinity 
of the ligand towards the proton, reducing the competition with the metal ion. The 
acidity  of  the  hydroxyl  group  in  position  3  is  increased  thanks  to  the  electron-
attracting property of the substituent in position 2, and thanks also to the energy 
stabilization induced by the ionized molecule: this is the result of the deprotonation 
process, and leads to an intramolecular hydrogen bond (which does not interfere with 
the metal coordination) between the –OH and the substituent in position 2. 
 
 
Figure 2.3: other proposed molecole for the Al and Fe chelation therapy 
 
 
 
2.3  AIM OF THIS THESIS WORK 
This thesis is included in a work project which focuses on the evaluation of selected 
HPCs as possible chelating agents for iron and aluminium. The involved research 
groups are the ones coordinated by dr. Valerio Di Marco, dr. Maria Grazia Ferlin and 
prof. Cristina Marzano from the University of Padova, and by prof. Tamás Kiss from 
the University of Szeged (Hungary).  
As seen, the only but important disadvantage of the HPCs studied so far is that their 
Al
3+ and Fe
3+ complex stability, despite being very high, is still lower than that of 
available  chelators  such  as  L1.  The  methyl  substitution  of  the  pyridine  ring 
demonstrated to be beneficial to increase the complex stability, but was not enough 
as it did not allow to at least reach the pM values displayed by the chelators presently 
in use, such as L1.   
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To  this  connection,  an  alternative  strategy  to  synthesize  stronger  HPC  chelators 
could be the insertion of another chelating group, e.g. a second carboxylate, on the 
pyridine ring. This second COOH should be added in ortho to the hydroxy group. In 
this  way,  a  more  probable  coordination  is  expected  towards  the  toxic  metal  ion 
(statistical  effect).  Furthermore,  the  second  carboxylate  group  should  favour  the 
deprotonation of the hydroxy group, by both an electronwithdrawing effect and an 
intramolecular  hydrogen  bond  formation.  In  this  way,  the  Lewis  basicity  of  the 
phenolic group should be enhanced, and complex formation should eventually be 
favoured.  It  is  also  interesting  to  evaluate  if  the  simultaneous  methyl-carboxy 
substitution would be beneficial to enhance the complex stability. 
In order to evaluate both the second carboxylate and the double carboxylate – methyl 
effects on complex formation,  two new HPC derivatives have been synthesized and 
studied: 4-hydroxy-3,5-pyridinedicarboxylic acid (DQ58) and 4-hydroxy-1-methyl-
3,5-pyridinedicarboxylic  acid  (DQ71508).  These  new  compounds  are  shown  in 
Figure 2.4.  
A parallel work was conducted in Padova and in Szeged on these ligands. In Padova, 
the complex formation of DQ58 and DQ71508 was performed with Al
3+ and Fe
3+, in 
order  to  evaluate  their  complexation  strength  towards  these  toxic  metal  ions.  In 
Szeged, the complex formation of the same ligands was performed with Cu
2+ and 
Zn
2+, in order to evaluate their complexation strength towards the selected essential 
metal ions. This thesis work regards the DQ58 and DQ71508 complexation towards 
Zn(II), and the DQ58 complexation towards Cu(II). 
Furthermore, the work in Szeged regarded also the complex formation study of 4-
pyridoxic  acid  (Figure  2.4)  (POA)  with  Al
3+,  Cu
2+  and  Zn
2+.  Despite  being  an 
important metabolite of vitamine B6, the complex formation properties of this HPC 
derivative have been never investigated so far. Another study performed within this 
thesis is the coordination chemistry of POA towards Al(III) and Zn(II). 
 
 
Figure 2.4: 4-hydroxy-3,5-pyridinedicarboxylic acid (DQ58); 4-hydroxy-1-methyl-3,5-
pyridinedicarboxylic acid (DQ71508); 3-hydroxy-5-(hydroxymethyl)-2-methyl-4-
pyridinecarboxylic acid (POA). All ligands are shown in their completely protonated forms 
(H4L
+, H3L
+ and H3L
+, respectively) 
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3  STUDY OF COMPLEX EQUILIBRIA 
 
There are several techniques available for the study of complex equilibria. In the 
following paragraphs, the methods which have been used in the frame of this thesis 
will be described: potentiometry, UV-Vis, NMR, EPR. 
 
3.1  POTENTIOMETRY 
3.1.1  Introduction 
Protonation constants of the ligands, β(HrL), and the overall stability constants of the 
metal complexes, β(MpLqHr), can be determined by pH-potentiometric titrations at 
equilibrium. Whereas the proton is a product or a reagent of the acid-base reaction 
under study, no proton may appear in the stoichiometry of the complex formation. In 
this  case,  pH-potentiometry  can  anyway  give  the  requested  information,  because 
there is a competition between H
+ and metal ion for the binding sites of the ligand 
(e.g. 3.1): 
 
qHL + M
m+   ⇌  MLq
(m-q)+ + qH
+            (3.1) 
 
Therefore,  the  stability  of  the  metal  complex  can  be  measured  via  the  H
+  (pH) 
changes.  Equilibrium  equations  for  the  formation  of  the  metal  complex  can  be 
described by the following general chemical equation (3.2): 
 
pM + qL + rH   ⇌  MpLqHr              (3.2) 
 
where M denotes the metal ion, L the completely deprotonated ligand and H the 
proton (charges are omitted for simplicity).  The overall stability constants  of the 
species can be defined according to equation (3.3): 
 
      
        
                           (3.3) 
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3.1.2  Glass electrode 
The electrode potential  difference between  a reference  electrode and  a reversible 
working  electrode  inserted  in  the  solution  is  measured  in  the  potentiometric 
measurements.  The  reference  electrode  is  generally  a  Ag/AgCl/KCl,  whereas  the 
working electrode in pH-potentiometric measurements is practically always the glass 
electrode. Nernst equation (3.4) provides the relationship between the potential (E) of 
the glass electrode and the concentration of the electrode active component H
+: 
 
E = E
0 + (RT/nF) ln[H
+]              (3.4) 
 
Where: E
0 is the standard potential of the electrode. It is a constant that includes 
various  contributes:  the  standard  potential  of  the  internal  Ag/AgCl/Cl
− 
electrode, the one of the external reference, and the asymmetry potential of 
the membrane; 
R is the universal gas constant (8.314 J/mol K); 
T is the absolute temperature (K); 
n is the number of moles of electrons transferred in the cell reaction or half-
reaction; 
F is the Faraday constant (96487 C/mol). 
 
RT/F is called the Nernst slope. Changes of the electrode potential is measured as a 
function of the volume of the titrant and the titration curve is recorded (cm
3-pH data 
pairs).  
Combination glass electrode (Figure 3.1) can be used for the measurements, in which 
the indicator (H ion-selective) and the reference (Ag/AgCl/KCl(3M)) electrodes are 
conveniently placed in one single housing.  
pH range 2-12 can be usually measured precisely by a H ion-selective electrode. 
However,  two  errors  may  influence  and  eventually  reduce  this  pH  range.  In  the 
presence of Na
+ or K
+ ions (which can be added e.g. with the titrant NaOH or KOH), 
the electrode response is non-linear at the alkaline pH range, and the pH measured is 
lower  than  the  actual  value.  This  phenomenon  is  called  alkaline  error,  and  it 
generally appears at pH > 11 in the case of Na
+ ions. The glass electrodes currently 
used are made of special  types  of glass, which significantly reduces  the alkaline 
error; the value of the latter can in any case be determined by dedicated experiments. 
Another error can be due to absorption of acidic molecules by the gel layer at very 
acidic pH, leading to a decrease in the hydrogen ion activity in the gel layer. This 
error is called acidic error, and the pH measurement shows a higher pH than the 
actual value of the solution.   
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Figure 3.1: schematic representation of the combination glass electrode 
 
3.1.3  The ionic strength control 
Complexation measurements typically require the use of an inert electrolyte, that is 
present in large excess compared to the other species, to ensure a constant ionic 
strength during the experiment. This allows to assume constants, at least as a first 
approximation, the activity coefficients of the species at equilibrium. Therefore, in 
the determination of the formation constants, it is sufficient to know only the species 
concentrations. The so obtained constants are defined "stoichiometric", as they are 
dependent on the environment in which the measurement is performed. They are 
different from the thermodynamic constants which need the activity values instead of 
concentration ones.  
The electrolyte should not interact with the species in solution (metal and ligand), 
because  it  is  rather  impossible  to  determine  any  complex  formed  between  the 
electrolyte and these species; for this reason, salts of alkali metals and single charged 
anions  are  usually  used  [Rossotti  1961],  such  as  sodium  perchlorate,  potassium 
chloride, sodium chloride, etc. In this thesis work KCl 0.2 M was used. K
+ was 
chosen because the titrant KOH is less subjected to carbonation than NaOH and Cl
− 
was chosen due to its physiological and environmental importance; the 0.2 M value 
represents  a  compromise  between  a  physiological  and  environmental  (sea  water) 
solution, and it has been used since long time by the research group of Szeged.   
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3.1.4  The experimental titrations 
The titrations are generally performed by mixing a strong acid and the ligand (and/or 
the metal ion), so that to obtain an acidic (ca. pH = 2) starting solution. The samples 
also contain KCl providing the constant ionic strength (0.2 M). This solution is then 
titrated  by  a  strong  base.  The  titrations  are  generally  performed  by  automatic 
titrators, which add a suitable volume of titrant in a vessel containing the acidic 
starting solution, measure the pH, wait until equilibrium is reached (i.e. until pH is 
stable), then perform another addition of titrant. These procedures are repeated until 
titration end, which is generally represented by a basic pH values (e.g.12). Therefore, 
the almost entire pH region from acidic to basic pH is covered by pH-potentiometric 
titrations. The stability constants are obtained by using suitable computer programs. 
3.1.5  Determination of the ligand protonation constants 
For  the  ligand  titrations,  the  stability  constants  are  obtained  using  the  computer 
program HYPERQUAD vers.2008. HYPERQUAD needs the following input data: 
 
  V0: starting volume of the sample (cm
3); 
  nligand (mmol): amount of ligand; estimated value based on its weight  and 
molecular weight; 
  nH (mmol): amount of acidic protons; estimated value is given by r×nligand + 
nHCl, where r is the proton content of the ligand, and nHCl is the amount of 
strong acid added; 
  VKOH vs. pH points: data points of the titration curves; the pH values are 
corrected by the Irving factor; 
  cKOH: concentration of the titrant (mol/dm
3); 
  Irving factor (IRV): it is the difference between the measured and calculated 
pH during a strong base-strong acid titration, when concentrations are known 
and the pH contribution given by the autoprotolysis of water is negligible; 
  pKw: autoprotolysis constant of water; 
  logβ (HrL) presumed. 
 
The HYPERQUAD program solves the following equation system (3.5): 
 
        
     
          
 
                           
   
                (3.5) 
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(n is the number of the species) 
The presumed protonation constants and the values of cL and cH are refined by the 
program in order to find the best fit between the measured and calculated titration 
curves. This non-linear fitting is performed through an iteration procedure. 
The proton dissociation constants (pKr) can be calculated easily from the protonation 
constants. For example, in the case of a ligand containing three dissociable protons, 
the relations are (3.6): 
 
logβHL = pK3; logβH2L = pK3 + pK2; logβH3L = pK3 + pK2 + pK1     (3.6) 
  
3.1.6  Determination of the metal-ligand complex formation constants 
For the determination of the stoichiometry and stability constants of metal-ligand 
complexes, the two computer programs PSEQUAD and HYPERQUAD were used. 
When they have been used together, identical stability constant values (within the 
experimental uncertainty) have been obtained. The input data for PSEQUAD are the 
same listed before for SUPERQUAD, and in the case of metal-ligand mixtures they 
include also the amount of metal ion.  
The overall stability constants are calculated by solving the mass balance equations 
(3.7): 
 
                       
     
     
   
       
 
                       
     
     
   
             (3.7) 
 
                       
     
     
   
       
 
The  correct  speciation  (i.e.  the  number  and  the  stoichiometry  of  the  species)  is 
obtained indirectly, by comparing the fitting results of different speciation models: 
the model giving the best fit corresponds to the correct speciation in solution. 
3.1.7  Limitations of pH-potentiometry 
In potentiometry, as seen, the concentration of [H3O]
+ is only indirectly affected by 
the  metal-ligand  complex  formation.  Therefore,  while  in  simple  systems  the 
interpretative model is unique, in systems with multiple complexes it may happen 
that  some  of  them  change  the  pH  only  marginally.  Therefore,  many  speciation 
models can be acceptable, and the correct choice requires a large number of titrations 
at very different conditions.   
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Another disadvantage of the method is that it is unable to provide reliable results 
when  the  pH  is  less  than  2.  This  is  not  only  due  to  the  acidic  error  described 
previously, but also to the impossibility to discriminate the [H] change due to the 
complexation  equilibria  when  [H]  is  very  high.  Furthermore,  the  liquid  junction 
potential  of  the  reference  electrode  is  not  more  negligible  at  acidic  pH,  thus 
inaccurate pH value measurements are obtained. 
Finally, the technique requires the analyzed system to be in equilibrium conditions 
during the titration; otherwise, the measured pH cannot be directly correlated to the 
composition  of  the  solution.  Consequently,  the  speed  of  the  reactions  must  be 
sufficiently  high  (usually  within  minutes,  exceptionally  few  hours),  since  the 
calibration parameters of the glass electrode (E
0 and Nernst slope) slowly change 
over time and may introduce systematic errors if the titration times become too large. 
 
 
3.2  UV-VIS SPECTROSCOPY 
3.2.1  Introduction 
Photons of UV and visible light can have enough energy to cause transitions between 
the  different  electronic  energy  molecular  levels.  These  transitions  result  in  very 
broad absorbance bands as they are due to vibrational and rotational energy levels 
superimposed  on  the  electronic  ones.  The  broadening  is  even  more  evident  in 
solutions because of solvent-solute interactions. The amount of light absorbed by a 
sample is expressed as either transmittance (3.8) or absorbance (3.9) according to the 
following equations: 
 
T = I/I0    or    % T = 100 I/I0              (3.8) 
 
A = −log T                  (3.9) 
 
where  I0  is  the  intensity  of  the  incident  radiation,  and  I  is  the  intensity  of  the 
transmitted radiation. For most applications, absorbance values are used since the 
relationship between absorbance and both concentration and path length, known as 
Lambert-Beer equation, is linear in most experimental conditions (3.10).  
 
A = ε b c                  (3.10) 
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where ε is the molar absorptivity [L mol
−1 cm
−1], b is the path length of the sample 
[cm], and c is the concentration of the compound in the solution [mol L
−1]. 
Absorbance by organic compounds results from the presence of a chromophore in 
the molecule. A chromophore is a molecular group usually containing conjugate π 
bonds, but it can also have different characteristics. The main transitions responsible 
for the chromophore character are π → π*, n → σ*, and n → π*. These absorptions 
typically fall in the 185-1000 nm wavelength range. 
As UV-visible spectra generally show only few broad absorbance bands they provide 
a limited amount of qualitative information. However, the presence of an absorbance 
band at a particular wavelength can be a good indicator of the presence of a specific 
chromophore, despite the exact position of the absorbance maximum is not fixed but 
depends  partially  on  the  molecular  environment  of  the  chromophore  and  on  the 
solvent  in  which  the  sample  is  dissolved.  Other  parameters,  such  as  pH  and 
temperature, also may cause changes in both the intensity and the wavelength of the 
absorbance  maxima.  The  conjugation  of  more  double  bonds  increases  both  the 
intensity and the wavelength of the absorption band. 
There can be more than one type of electronic transitions, or excitations, taking place 
depending upon the nature of the chromophore(s) involved: the spectrum obtained is 
the combination of the different types of transitions occurring within the compound. 
For instance, if the ligand of a metal-ligand complex contains a chromophore which 
is not directly engaged in the metal binding, the ligand can absorb UV-Vis radiation 
in the same way as it would do on its own. The absorption due to the ligand therefore 
forms part of the spectrum for the particular complex. Transition metal ions, have 
peculiar electronic energy levels that cause absorption at 400–700 nm.  
Four different types of electronic transitions in metal complexes can occur: 
 
  d-d transitions: they are related to excitation of an electron from the lower to 
the upper d level of the metal ion; 
  f-f  transitions:  caused  by  the  electrons  in  the  f  levels  with  the  same 
mechanism  as  for  d-d  transitions.  Bands  are  of  extremely  low  intensity; 
furthermore f orbitals, being deeply buried in the interior of the metal atoms, 
are very little affected by any ligand crystal field effects;  
  LMCT (Ligant-to-Metal Charge Transfer) transitions: charge transfer (CT) 
transitions  involve  the  movement  of  a  charge  from  one  atom  to  another 
during the electronic transition. If an electron is in a molecular orbital (MO) 
that is primarily located on the ligand and gets excited to a MO that is located  
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on the metal cation, there is a ligand-to-metal charge transfer transition. Such 
transitions are usually very intense; 
  MLCT (Metal-to-Ligand Charge Transfer) transitions: if the CT band in an 
electronic spectrum is associated with an excitation of an electron from a d 
orbital  (metal-centered)  to  a  ligand-centered  MO  (in  most  cases  an 
antibonding MO), a metal-to-ligand charge transfer transition occur.  
 
3.2.2  UV-Vis spectra evaluation 
The  processing  of  spectrophotometric  data  is  conducted  similarly  to  that  of  the 
potentiometric  data  (see  paragraphs  3.1.5  and  3.1.6)  and  by  the  same  computer 
programs. The only difference is that in this case the theoretical and experimental 
magnitude which is compared during the fitting procedure is the absorbance A, which 
is additive in a mixture. For example, in a solution containing metal and ligand, A is 
given by the relation (3.11): 
 
A = εM b [M] + εL b [L] + ∑ εi b ( βpqr)i [M]
p [L]
q [H]
r  (3.11) 
 
where: 
  εi is the molar absorptivity (at the selected wavelength λ) of the species I, 
which might be zero for certain compounds; 
  (βpqr)i are the overall formation constants as defined by equation (3.3), which 
include  also  the  protonation  constants  of  the  ligand  and  the  hydrolysis 
constants of the metal ion. 
Hence, the fitting procedure requires to the values for ε in addition to those of β.  
 
3.2.3  A comparison between potentiometry and UV-Vis spectroscopy 
UV-visible spectroscopy has some advantages when compared with potentiometry. 
For example there is the possibility to operate at lower analytical concentrations than 
in  potentiometric  titrations:  whereas  the  latter  requires  at  least  an  analyte 
concentration equal to 2·10
−4 M (as below this value data are not interpretable), UV-
visible  spectroscopy  allows  to  work  at  concentrations  as  low  as  about  10
–5  M, 
provided that the relevant  values are high enough. Spectroscopy techniques allow 
to  operate  at  very  acidic  (or  very  basic)  pH,  because  no  electrode  is  required. 
Furthermore,  UV-visible  measurements  are  not  limited  by  the  speed  of  the 
complexation reactions, because there is no problem to wait even very long times 
before  performing  the  measurement.  Another  important  advantage  of  UV-visible  
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measurements  is  that  they  might  give  structural  information  about  the  complex. 
Finally,  these  measurements  are  generally  faster  and  simpler  than  potentiometric 
ones. 
The only, but very important, disadvantage of UV-visible spectroscopy is that data 
obtained are generally less accurate than data obtained with potentiometry. This is 
due to the intrinsic poor resolution of the UV-visible spectra, since absorption bands 
of the ligand, and/or metal complexes are usually overlapped, making it difficult to 
separate the various components of the signal. Another problem which affect the 
accuracy of the fitted data is that more parameters have to be fitted for UV-Vis data 
than  for  potentiometric  titrations,  as  also  the    values  and  not  only  the  stability 
constants are unknown. The situation is much worse if many complexes coexist in 
solution, and if the spectra of metal-ligand complexes, as commonly happens, are 
very similar each other and to those of the free ligand or of the free metal. 
For  this  reason,  the  UV-visible  spectroscopy  is  usually  used  mostly  to  verify 
potentiometric data, or to study solutions with very slow kinetics, or at extreme pH 
values. 
 
 
3.3  EPR 
3.3.1  Introduction 
Electron paramagnetic resonance (EPR) spectroscopy allows to detect electron spin 
transitions of permanent or temporary paramagnetic species, which include organic 
and  inorganic  free  radicals,  molecules  in  the  triplet  electronic  state,  metals  and 
semiconductors  with  conduction  and/or  valence  bands,  defects  in  crystals  and 
systems containing transition metals ions. 
According to  quantum mechanics,  the angular  momentum  of the electron spin is 
associated  with  an  angular  momentum  quantum  number  S  =  ½.  The  two  spin 
eigenstates of the electron, denoted by |α> and |β> respectively, are degenerative in 
the absence of an external magnetic field. The application of a magnetic field causes 
the two energies to become different, because of the Zeeman interaction. 
The separation in  energy  between the two states  depends on the intensity of the 
magnetic field according to the equation (3.12): 
 
                                    (3.12) 
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where  μB  and ge are the Bohr magneton  (μB  =9.72·10
−23 J T
−1) and the  g factor 
(ge=2.0023 for the free electron) respectively, and B0 is the magnetic field.  
An unpaired electron can pass from one energy level to another absorbing or emitting 
an amount of energy equal to the energy gap between states α and β, in order to 
verify  the  resonance  condition  described  by  equation  (3.12)  and  schematized  in 
Figure 3.2. 
In EPR technique with a continuous wave, this condition is obtained by varying the 
magnetic field and irradiating the sample at a constant frequency.  
 
 
Figure 3.2: schematic representation of Zeeman effect, that is the separation in energy of 
electronic states α and β in the presence of an external magnetic field. 
 
In molecules there are no individual unpaired electrons, because they are associated 
with one or more atoms, and the value of g can differ considerably from that of the 
free electron. This is due to the interaction of the spin magnetic moment S with the 
orbital angular momentum L. This coupling is known as spin-orbit coupling. As a 
consequence, a  local  magnetic field  is  generated, that  is  added vectorially to  the 
external field. The spin-orbit coupling is very important in solid state EPR, as only in 
solid samples (polycrystalline powder or frozen solution) anisotropy is preserved and 
the paramagnetic species can experiment all possible orientations with respect to the 
field. Therefore, the principal values of the tensor g can be determined. In solution, 
where paramagnetic molecules move rapidly and erratically, only an average value 
of g can be measured. 
Another information which can be obtained from an EPR spectra comes from the 
Hyperfine coupling. Some nuclei possess an intrinsic spin angular momentum (I) 
associated  with  a  magnetic  moment.  Consequently,  the  effective  magnetic  field 
which affects the electrons is also a function of the magnetic field generated by the 
nuclei. If the electron magnetic moment is coupled with the magnetic moment of a 
nucleus,  the  possible  electronic  transitions  are  2I+1  (I  is  the  nuclear  quantum  
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number). The relationship between the intensity of lines in the spectra arise from the 
Tartaglia  triangle,  and  the  separation  between  them  is  given  by  the  hyperfine 
coupling constant, A. The constant A depends on the orientation of the paramagnetic 
molecules relative to the direction of the magnetic field.  
3.3.2  EPR signals of copper 
Among  the  metal  ions  considered  in  this  thesis  work,  Cu
2+  gives  EPR  signals 
because its electron configuration is d
9, so it has an unpaired electron in a d orbital 
and electronic spin S = ½. Copper is present as a mixture of isotopes 
63Cu (69.2%) 
and 
65Cu (30.8%), having nuclear spin I = 3/2. Its EPR spectrum in continuous wave 
(CW-EPR) is reported in Figure 3.3. Thanks to the hyperfine interaction, four lines 
separated  by  the  constant  A//  are  obtained.  The  hyperfine  coupling  A⊥,  which 
originates from the nuclear magnetic moment of Cu
2+ for g⊥, is normally very small, 
so this part of the spectrum does not show any splitting. The parallel region has 
typically g = 2.2-2.3, while for the perpendicular region g varies from 2.03 to 2.06. 
 
 
Figure 3.3: CW-EPR spectrum of a Cu(II) compound 
 
3.3.3  EPR spectra evaluation 
The EPR spectra can be simulated using suitable programs, and the relevant stability 
constants can be obtained, similarly as described before, by comparing the simulated 
and the experimental spectra. The complete procedure is described in the papers of 
Rockenbauer  et  al.,  who  first  proposed  to  use  EPR  for  the  copper  complexation 
studies [Rockenbauer 2001]. 
Differently than for potentiometric and UV-Vis elaborations, here the anisotropic 
EPR parameters and the orientation dependent linewidth parameters should be fitted 
in  addition  to  the  stability  constants.  Due  to  this  large  numbers  of  parameters,  
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potentiometric and other spectroscopic results must be available to allow the fitting 
procedure  on  EPR  data  to  succeed,  i.e.,  EPR  cannot  be  used  as  independent 
technique in complexation studies.  
The elaborations of the EPR spectra obtained during this work is still in progress. 
Therefore, no EPR results can be presented at this stage.   
 
 
3.4  NMR SPECTROSCOPY 
3.4.1  Introduction 
The  NMR  (Nuclear  Magnetic  Resonance)  phenomenon  is  produced  if  a  nucleus 
having magnetic properties (nuclear spin) is inserted in a magnetic field  B0.  The 
nuclear magnetic moment of a nucleus aligns with B0 in 2I+1 ways, either with or 
against the applied field. For example, for a single nucleus with I = ½ two new 
energy levels are generated, named α (lower energy level) and β. The rotational axis 
of the spinning nucleus cannot be orientated exactly parallel (or anti-parallel) with 
the direction of the applied field, but must precess about this field at an angle, with 
an angular velocity given by the expression (3.13): 
 
                                  (3.13) 
 
Where  ω0  is  the precession  rate which is  also  called the  Larmor frequency.  The 
magnetogyric ratio (γ) relates the magnetic moment (μ) and the spin number (I) for a 
specific nucleus (3.14): 
 
                           (3.14) 
 
Each nucleus has a characteristic value of γ. For example, for 
1H, γ = 2.674·10
4 
gauss
−1 sec
−1. This precession process generates an electric field with frequency ω0. 
If the sample is irradiated with radio waves in the MHz frequency range, the nucleus 
absorbs the energy and is promoted to less favorable higher energy state thus causing 
a magnetic transition.  
3.4.2  Sigma electrons and electronic shielding 
Electrons are negatively charged particles that surround nuclei within a molecule. It 
is  well known  that moving charged particles  generate a magnetic field.  In NMR 
spectroscopy, the lines of force of this electron-generated magnetic field run in the 
opposite direction as the lines of force generated by the external magnetic field B0.  
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This has the effect of reducing the net magnetic moment affecting the nuclei. The 
electronic magnetic field effect causes nuclei with different chemical environments 
to yield resonance frequencies perturbed from the frequency defined by the applied 
external field B0. 
The Larmor frequency can be re-written to include the electronic effect (3.15): 
 
                                (3.15) 
 
where S represents the change in magnetic field caused by the opposing electron 
magnetic moment, that is, all electrons making up the sigma bonding around the 
nuclei generate a magnetic field that is anti-parallel to the external magnetic field 
force  lines.  This  causes  the  NMR  signal  generation  to  occur  at  higher  external 
magnetic field setting. NMR signals are shifted upfield, and nuclei are said to be 
electronically shielded. The sharpness of the NMR signals (at least for nuclei with I = 
½), and the sensitivity of the shifts on the chemical surroundings of the atom, allow 
the powerful use of NMR as a qualitative tool for the identification of the molecule 
under exam. 
The shift is generally measured relative to the signal of a reference compound, which 
is  usually  tetramethylsilane  (TMS)  or  similar  compounds,  as  e.g.  the  analogous 
water-soluble  trimethylsilane-propionic  acid.  The  association  with  the  reference 
signal is called chemical shift and it is measured in parts per million (ppm).  
3.4.3  NMR spectroscopy in the study of complex formation 
NMR spectroscopy can be applied to the study of metal-ligand complex formation, 
since  it  allows  a  qualitative  (and  sometimes  semi-quantitative)  analysis  of  the 
complexation. NMR spectra can provide the number of species existing in solution 
and in some cases their structure, while the signal integration is related to the relative 
abundance  of  the  particular  complex.  These  information  can  be  acquired  either 
through the evaluation of the electronic effects exercised by the ligand on the metal 
(by nuclear spectroscopy of the metal) or, on the opposite, considering the effects 
generated  by  the  metal  on  the  ligand  (by  NMR  studies  of  e.g. 
1H  nuclei  of  the 
ligand).  
In complexometric analysis in which aluminium is involved, there is the possibility 
to study directly the metal center, because the isotope 
27Al is very sensitive to this 
technique, thanks to its high gyromagnetic ratio and to its large isotopic abundance, 
close  to  100%.  Despite  this, 
27Al  NMR  spectra  are  often  difficult  to  interpret, 
because aluminium nucleus has a quadrupole moment which broaden NMR peaks 
when, as usually happens, the metal ion is in the center of an asymmetric electronic  
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distribution.  Therefore, 
1H  spectroscopy  on  the  ligand  is  better  suitable  to  study 
aluminium  complex  formation.  A  specific  advantage  of  aluminium  is  its  kinetic 
inertia, that allows to obtain 
1H spectra with very narrow lines for each of the species 
formed in solution. For Zn
2+ and for many other atoms, on the other hand, the very 
high complex formation speed does not allow to obtain separate NMR lines: one 
single line is rather obtained for each proton, and its chemical shift is a weighted 
average between the chemical shifts due to that proton in the different complexes. 
For  Cu
2+  and  for  other  paramagnetic  atoms,  finally,  the  technique  is  even  less 
suitable,  because  the  magnetic  field  generated  by  unpaired  electrons  shorten  the 
relaxation times of the nuclear spins, leading to a consequent widening of the signals. 
This can be so pronounced, that the signals themselves may disappear. 
3.4.4  Isotopic effects 
If 
1H-NMR spectra have to be obtained in water, it is advisable to minimize the 
strong interference due to the water protons by using heavy water (D2O) as solvent. 
This, however, introduces isotopic effects, which mainly affect equilibrium constants 
if H3O
+ is directly involved in the reaction (primary isotope effects), and to a lesser 
extent all the other constants in solution through a "solvent effect". 
Although  the  metal-ligand  complexation  constant  is  not  directly  affected  by  the 
deuterated solvent,  the  effective  strength  of the complex changes  significantly in 
heavy water because the competition for the ligand of H
+ is different than that of D
+. 
On the other hand, the similarity of the two solvents makes it very improbable that 
qualitative changes occur, hence the number and the stoichiometry of the species 
present  are  generally identical.  NMR  study of  metal-ligand complexes  in D2O is 
therefore expected to provide reliable qualitative information. 
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4  EXPERIMENTAL 
 
 
4.1  INSTRUMENTS  
  Orion 710A pH-meter  
  Metrohm combined electrode (type 6.0234.1000)  
  Automatic titrator  Metrohm 665 Dosimat equipped with 1 mL and 5 mL 
burettes  
  Measuring cells of 20 mL and 10 mL  
  Thermostat which provides a constant temperature 25.0 ± 0.1°C 
  Analytical balance 
  Technical balance Gibertini TM 560–2R (Padova)  
  BRUKER EleXsys E500 spectrometer (microwave frequency ~9.7 GHz, 
microwave  power  13mW,  modulation  amplitude  5  G,  modulation 
frequency 100 kHz). 
  Heidolph Pumpdrive 5101 peristaltic pump to circulate the solution from 
the  titration  pot  through  a  capillary  tube  into  the  cavity  of  the  EPR 
instrument. 
  Hewlett Packard 8452A diode array spectrophotometer 
  1 cm quartz cuvette 
  Crison glass electrode, calibrated with two buffer solutions: 
  stabilized  solution  of  sodium  and  potassium  phosphates, 
“Labochimica”, pH=7 ± 0.02 (20°C) 
  stabilized citric acid, HCl and NaOH solution, "Titolchimica",   
pH = 4.00 ± 0.02 (20 ° C) 
  NMR Bruker DRX-400 spectrometer, frequency 400.13 MHz 
 
 
4.2  REACTANTS 
  Potassium hydrogen phthalate (Sigma Aldrich >98%) 
  Hydrochloric acid (Merck, 36 % m/m) 
  Potassium hydroxide (Merck, > 86%) 
  Potassium chloride (Sigma Aldrich, > 98%)  
 
54 
 
  4-hydroxy-3,5-pyridinedicarboxylic acid (DQ58), synthesis product of the 
research groups of D. Marton and M. Grazia Ferlin, University of Padova 
  4-hydroxy-1-methyl-3,5-pyridinedicarboxylic acid (DQ71508), synthesis 
product  of  the  research  groups  of  D.  Marton  and  M.  Grazia  Ferlin, 
University of Padova 
  2-Methyl-3-hydroxy-4-carboxy-5-hydroxymethylpyridine, or 3-hydroxy-
5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylic acid (POA), Aldrich 
  Zn(II)  solution,  prepared  by  dissolution  of  anhydrous  ZnCl2 
(SigmaAldrich)  in  a  known  amount  of  HCl  (Merck,  36%).  [Zn
2+]0  = 
0.09721 M, [H
+]0 = 0.00669 M 
  Cu(II) solution, prepared from CuCl2·2H2O (Reanal, > 98%) dissolved in 
doubly distilled water. [Cu
2+]0 = 0.08828 M  
  Al(III)  solution  prepared  by  dissolution  of  AlCl3  (Sigma  Aldrich)  in 
doubly distilled water. [Al
3+]0 = 0.100992 M, [H
+]0 = 0.0216 M 
  Ethylenediaminetetraacetic acid (EDTA) (Sigma Aldrich, > 99%) 
  methyltimol blue indicator 
  hexamethylenetetramine buffer 
  Deuterium  oxide,  "Aldrich",  nominal  concentration  99.9%  deuterium 
atoms 
  DCl, Janssen Chemical, 20 wt% solution in D2O, 99% deuterium atoms 
  NaOD, Aldrich, 40 wt% solution in D2O, 99.9% deuterium atoms 
  Zinc oxide, Aldrich 99.9% 
  Aluminium  trichloride  hexahydrate,  "Aldrich",  nominal  concentration 
99% 
  3–(trimethylsilyl)  propionic  acid,  sodium  salt  (TMSP),  "Aldrich", 
minimum concentration 99% 
 
 
4.3  PREPARATION OF THE SOLUTIONS 
All  the  solutions  used  for  pH-potentiometric  titrations,  UV-Vis  and  EPR 
measurements  were  prepared  by  dissolving  the  reagents  in  a  known  volume  of 
doubly-distilled  Milli-Q  water,  and  the  temperature  was  set  at  25  °C.  The  exact 
concentrations (expressed in molarity M, mol/L) of the stock solutions prepared were 
determined  by  potentiometric  titrations,  using  the  programs  HYPERQUAD  and 
PSEQUAD for data evaluation. The solutions used for NMR measurements were 
prepared by direct weighing of the analytes and the solvent.   
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To all ligand stock solutions (except those for NMR measurements) an appropriate 
quantity of hydrochloric acid and kalium chloride was added, in order to reach a pH 
of around 2 and a ionic strength of KCl 0.2 M.  
4.3.1  Potassium hydrogen phthalate solution 
Two different solutions of potassium hydrogen phthalate were prepared. The first 
one was prepared at an accurate concentration of 0.05 M and it was used as standard 
buffer solution to calibrate the pH-meter: at this concentration and at T = 25 ° C, pH 
=  4.01  by  definition.  This  solution  was  prepared  every  2-3  days  to  ensure  the 
maintenance of the exact concentration. 
The second potassium hydrogen phthalate solution was prepared by diluting the first 
one with doubly distilled water, and adding KCl to obtain a ionic strength of 0.2 M. 
This solution was used repeatedly to titrate the KOH solution, in order to obtain its 
exact concentration.  
4.3.2  KCl solution  
The strong electrolyte KCl was used to keep the ionic strength (I) constant in all 
samples. I was imposed to be 0.2 M and it was adjusted by suitable additions of 1 M 
KCl solution. 
The KCl 1 M stock solution was prepared by solubilising a weighed amount of salt in 
a known volume of water.  
4.3.3  HCl solution 
This solution was prepared by dilution of commercial HCl (37% m/m) with double-
distilled water. The HCl concentration was determined by potentiometric titrations 
with standardized KOH 0.1 M using Gran’s method, and it resulted 0.228 M ± 0.001. 
The  HCl  solution  was  used  in  HCl-KOH  titrations,  to  acidify  all  the  ligand  and 
metal-ligand solutions, and to vary the pH (if needed) in UV-Vis measurements.  
4.3.4  KOH solution 
0.1 M carbonate-free KOH solutions were used. They were prepared by dissolution 
of KOH pellets in freshly boiled double-distilled water, which was left to cool to 
room temperature under argon bubbling. An approximately double amount of KOH 
pellets  was  weighted,  and  its  surface  was  washed  out  in  order  to  remove  the 
carbonate-layer  before  adding  it  in  the  solution  flask.  In  order  to  keep  the  ionic 
strength  constant,  KCl  has  been  added  to  the  KOH  solution  to  set  the  K
+  - 
concentration = 0.2 M. A small amount of KOH solution was quickly titrated by HCl 
solution  with  known  concentration  to  check  the  correctness  of  the  0.1  M  KOH 
concentration,  and  after  the  solution  was  diluted  accordingly  if  necessary.  The  
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solution was poured into the burette under argon. The capillaries and the piston of the 
burette  had  to  be  rinsed  with  the  titrant  several  times  and  its  concentration  was 
determined  after  24  h  storage.  The  KOH  solution  was  than  standardized  against 
hydrogen phthalate, and it was used for ca. 3 weeks; after that time, a new titrant 
solution was prepared. 
4.3.5  Aluminium, zinc and copper solutions 
The aluminium, zinc, and copper solutions were prepared by dissolution of AlCl3, 
ZnCl2, and CuCl2 respectively in acidic aqueous solutions. Zn
2+ solution was directly 
titrated by EDTA standard solution in order to obtain its exact metal concentration. 
Al
3+ solution cannot be directly titrated by EDTA, as the complex formation reaction 
is fairly slow. Therefore, an excess EDTA and aluminium are allowed to react in a 
hot solution for several minutes. The reaction is allowed to proceed at acidic pH (2-
3) to avoid the metal hydrolysis. When almost all Al(III) is bound to EDTA, the pH 
is increased to ~9 in order to complete the complex formation. After several minutes 
extra boiling, the solution is cooled down, and the excess of EDTA is titrated by a 
Zn(II) titrant solution.  
This procedure is called back titration. The titration by Zn
2+ is performed at pH ~ 5 
(hexamethylenetetramine buffer) in the presence of methyltimol blue indicator. The 
H
+  concentration  was  obtained  by  direct  titration  of  the  metal  solution  by 
standardized KOH solution.  
4.3.6  DQ58 solutions 
Four DQ58 solutions were prepared, one for each different technique employed. All 
solutions were prepared by careful weighing of the ligand and dissolving it in doubly 
distilled  water.  The  following  concentrations  were  achieved:  ~2  mM  for  pH-
potentiometric,  EPR  and  UV-Vis  measurements  and  ~1.5  mM  for  NMR 
measurements. The solubility of DQ58 in water is slightly larger than 2·10
−3 M. The 
exact  concentration  of  the  potentiometric,  UV-Vis  and  EPR  solutions  was 
determined  by  repeated  titrations  with  the  standardized  KOH  solution.  DQ58 
solutions, when not in use, were stored in the refrigerator. 
4.3.7  DQ71508 solutions  
Five  DQ71508  solutions  were  prepared.  Two  of  them  were  used  for  pH-
potentiometric studies, the other three for UV-Vis, EPR and NMR measurements 
respectively.  All  solutions  were  prepared  by  accurately  weighing  the  ligand  and 
dissolving  it  in  water.  Solutions  for  pH-potentiometric  studies  were  prepared  at 
concentration 1.3 mM (to study the system DQ71508-Cu(II)) and 1.6 mM (to study 
the system DQ71508-Zn(II)). The concentrations for the UV-Vis, EPR and NMR  
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studies were ~1.3 mM. The solubility of DQ71508 in water is around 2.5·10
−3 M. As 
for DQ58, the exact concentration of the potentiometric, UV-Vis and EPR solutions 
was determined by repeated titrations with the standardized KOH solution. DQ71508 
solutions, when not in use, were stored in the refrigerator. 
4.3.8  POA solutions 
Three POA solutions were used. All solutions were prepared by accurately weighing 
the  ligand  and  dissolving  it  in  water.  The  concentration  reached  for  pH-
potentiometric  and  UV-Vis  measurements  was  ~2  mM,  while  the  concentration 
reached for NMR measurements was ~2.5 mM. The solubility of POA in water was 
not  determined,  but  it  overcomes  2.5  mM.  The  exact  concentration  of  the 
potentiometric and UV-Vis solutions was determined by repeated titrations with the 
standardized  KOH  solution.  POA  solutions,  when  not  in  use,  were  stored  in  the 
refrigerator. 
 
 
4.4  EXPERIMENTAL  PROCEDURE  FOR  PH-POTENTIOMETRIC 
TITRATIONS 
pH-potentiometric  measurements  were  performed  for  solutions  containing  the 
ligands alone (DQ58, DQ71508 or POA), and for solutions containing one ligand 
and one metal ion. The following metal-ligand solutions were studied: DQ58-Zn(II), 
DQ71508-Zn(II), DQ71508-Cu(II), POA-Zn(II), and POA-Al(III). DQ58-Cu(II) and 
POA-Cu(II) complexes have been studied in the frame of a different thesis work 
[Suba 2013]. The pH-metric measurements were carried out at an ionic strength of 
0.2 M KCl in aqueous solution. The titrations were performed in the pH range 2-11 
or until precipitation occurred in the samples.  
4.4.1  Instrumental apparatus 
The  potentiometric  measurements  were  performed  in  a  galvanic  cell,  whose 
temperature  is  stabilized  at  25.0  ±  0.2  °C,  thanks  to  a  water  circulation  cooling 
system. A 20 mL cell was used to titrate DQ58 and DQ71508, a 10 mL one was used 
for POA. Titrations were performed with a carbonate-free KOH solution of know 
concentration (ca. 0.1 M); the samples were in all cases deoxygenated by bubbling 
purified and saturated argon for some minutes before the measurements, and argon 
was also passed across the solutions during the titrations. The use of the argon flow 
is necessary in the cell when the solution reaches neutral or alkaline pH. In these 
situations, the carbonation would result in a constant drift of the pH to more acidic 
values, due to (4.1):   
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CO2 (g) ⇌ CO2 (aq.) 
CO2 (aq.) + 2 H2O ⇌ HCO3
– + H3O
+  (4.1) 
HCO3
– + H2O ⇌ CO3
2– + H3O
+ 
 
Before each titration, the glass electrode was calibrated with hydrogen phthalate, and 
the pH readings were corrected according to Irving et al. (strong acid vs. strong base 
titrations) [Irvin 1967]. 
A  homemade  computer  program  enables  the  automatic  management  of  the 
instrument,  controls  the  addition  of  the  titrant,  and  monitors  the  pH  when  the 
equilibrium is reached according to the given parameters. 
The following information and titration parameters are set: 
 
  Dosing unit: it specify which burette is working if many are connected to the 
PC and pH-meter 
  Name of the file 
  Concentration of the base solution 
  Initial volume of the sample 
  Cycle time: the pH has to be stabilized within pH ± 0.002 unit during a given 
period  
  Maximum cycle number: the pH is checked e.g. maximum 15 times 
  Volume of the first addition 
  Minimum volume of the titrant added 
  Maximum volume of the titrant added 
  Dose limit: the titration runs until a certain value of pH or Volume of titrant is 
added 
  pH difference: pH interval between one measurements and the following 
  waiting time before starting the titration 
 
An automatic titration is performed, and an output file is obtained reporting the pH 
values (from which the Irving factor must be subtracted) as a function of the titrant 
volume. This file is then used as input file by the computer programs HYPERQUAD 
and PSEQUAD.  
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4.4.2  Sequence of potentiometric titrations 
The calculation of the metal-ligand complex formation constants by potentiometric 
titrations,  and  therefore  the  titrations  of  metal-ligand  solutions,  require  to  be 
performed by sequential steps. 
First  of  all,  the  KOH  solution  has  to  be  standardized  with  potassium  hydrogen 
phthalate. This KOH solution is then used to standardize HCl, the metal and the 
ligand, and finally the metal-ligand solutions. 
4.4.3  KOH standardization with potassium hydrogen phthalate 
3 mL of a 0.05 M standard hydrogen phthalate solution were added to 13 mL of 
water and to 4 mL of KCl 1 M in order to obtain a ionic strength 0.2 M; this solution 
was then titrated with KOH. Table 4.1 shows the parameters chosen for all the KOH 
standardizations: 
 
Table 4.1: parameters for KOH standardization 
Cycle time (s)  10 
Max. cycle number   8 
Volume of the first addition (mL)  0.1 
Minimum volume of the titrant added (mL)  0.01 
Maximum volume of the titrant added (mL)  0.1 
Final pH  11.5 
 
4.4.4  Strong acid-strong base titrations 
The HCl-KOH titrations were performed once or twice a day in order to check the 
correct  functioning  of  the  potentiometric  system.  From  these  titrations,  the  exact 
concentration of the strong acid (HCl) solution, the Irving factor (IRV), and the water 
ionization  constant  (pKw)  can  be  determined.  The  requirement  for  a  correct 
functioning of the potentiometric system is that the same IRV and pKw values should 
be obtained in different titrations.  
The 20 mL titrated solution was composed by 0.6 mL of HCl, 15.4 mL of water and 
4 mL of KCl. Table 4.2 shows the parameters chosen for the titrations. 
 
Table 4.2: parameters for the strong acid-strong base titrations 
Cycle time (s)  10 
Max. cycle number   8 
Volume of the first addition (mL)  0.1 
Minimum volume of the titrant added (mL)  0.01 
Maximum volume of the titrant added (mL)  0.1 
Final pH  11.5 
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4.4.5  Titrations of solutions containing DQ58, DQ71508 or POA 
Titrations  of  each  ligand  were  carried  out  either  by  directly  titrating  each  stock 
solution (prepared as described in previous paragraphs), or by diluting it in a 1:1 v/v 
ratio and adding KCl in order to keep the ionic strength constant.  
Table 4.3 shows the parameters chosen for all the ligand titrations. 
 
Table4.3: parameters for the ligand titrations 
Cycle time (s)  15 
Max. cycle number   15 
Volume of the first addition (mL)  0.05 
Minimum volume of the titrant added (mL)  0.005 
Maximum volume of the titrant added (mL)  0.1 
Final pH  11.5 
Waiting time before starting  (s)  60 
 
4.4.6  Titrations of DQ58-Zn(II) solutions 
The ligand stock solution was added with a known volume of zinc solution and, if 
necessary, doubly distilled water and KCl, in order to obtain a 20 mL solution. The 
chosen ligand-to-metal ratios were 2:0.5, 2:1, 2:1.4, 1:0.5 and 1:0.9. Experimental 
parameters of the titrations are shown in Table 4.4. The starting acidic solutions were 
titrated  with  KOH;  titrations  were  stopped  when  a  precipitate  was  observed. 
Precipitation occurred at pH 6.4, 5.1, 4.8, 6.8 and 5.8 at the above listed ligand-to-
metal ratios, respectively.  
 
Table 4.4: parameters for the Zn(II)-ligand and Cu(II)-ligand titrations 
Cycle time (s)  15 
Max. cycle number   15 
Volume of the first addition (mL)  0.05 
Minimum volume of the titrant added (mL)  0.005 
Maximum volume of the titrant added (mL)  0.1 
Final pH  11.5 
Waiting time before starting  (s)  180 
 
The waiting time before the titration start was set at a value larger than zero to permit 
the complete complexation between the ligand and the metal after their mixing.   
4.4.7  Titrations of DQ71508-Cu(II) and DQ71508-Zn(II) solutions 
The ligand stock solution was added with a known volume of metal solution (copper 
or zinc) and, if necessary, doubly distilled water and KCl, in order to obtain a 20 mL 
solution. The chosen ligand-to-metal ratios were 2:0.5, 2:1, 2:1.8, 1:0.5 and 1:0.75 
for  copper,  2:0.5,  2:1,  2:1.75,  1:0.5  and  1:0.8  for  zinc.  Like  before,  the  starting  
 
61 
 
solution  was  titrated  with  KOH,  and  titrations  were  stopped  when  precipitation 
occurred.  For  copper,  a  precipitate  formed  at  pH  4.4,  3.4,  3.0,  4.1  and  3.4, 
respectively,  at  the  above  listed  ligand-to-metal  ratios.  For  zinc,  precipitation 
occurred at pH 8.5, 8.3, 7.9, 8.3 and 7.7, respectively. Experimental parameters are 
listed in Table 4.4. 
4.4.8  Titrations of POA-Zn(II) and POA-Al(III) solutions 
The  ligand  stock  solution  was  added  with  a  known  volume  of  metal  solution 
(aluminium or zinc) and, if necessary, doubly distilled water and KCl, in order to 
obtain a 10 mL solution. The chosen ligand-to-metal ratios were 2:0.5, 2:1, 2:1.8, 
1:0.5 and 1:0.9. For POA-Zn(II) solutions, precipitation occurred respectively at pH 
7.8, 7.7, 7.5, 7.7 and 7.6. For POA-Al(III) solutions, precipitation was not observed 
for the 2:0.5 ratio, whereas for the other ratios it occurred at pH 7.4, 5.1, 6.5 and 5.6, 
respectively.  Experimental  parameters  of  the  POA-Zn(II)  titrations  are  shown  in 
Table  4.4.  Experimental  parameters  of  the  POA-Al(III)  titrations  are  reported  in 
Table  4.5.  The  latter  are  different  from  those  used  for  the  other  metal-ligand 
titrations, because the complexation kinetic of Al(III) is much slower than that of 
Zn(II) and Cu(II). 
 
Table 4.5: parameters for the POA-Al(III) titrations 
Cycle time (s)  25 
Max. cycle number   15 
Volume of the first addition (mL)  0.05 
Minimum volume of the titrant added (mL)  0.005 
Maximum volume of the titrant added (mL)  0.1 
Final pH  11.5 
Waiting time before starting  (s)  320 
 
 
 
4.5  EXPERIMENTAL PROCEDURE FOR UV-VIS MEASUREMENTS 
UV-vis  spectrophotometric  measurements  were  performed  for  DQ58-Cu(II)  and 
DQ71508-Cu(II) solutions in order to obtain additional complexation data. Aqueous 
solutions at 25.0 ± 0.1 
oC and at ionic strength 0.20 M (KCl) were analyzed.  
4.5.1  Instrumental apparatus 
A Hewlett Packard 8452A diode array spectrophotometer was used to collect the 
UV-vis spectra in the interval 200–400 nm. The spectra were recorded under argon 
atmosphere. In the acquisition of all spectra the blank is represented by a solution of 
potassium chloride 0.2 M, and each solution contains KCl 0.2 M.  
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Protonation and stability constants and the individual spectra of the species were 
calculated by the computer program PSEQUAD. 
4.5.2  DQ58 solutions 
Starting from the DQ58 stock solution prepared, as explained in paragraph 4.3.6, a 
more  diluted  solution  (0.081  mM)  was  prepared  to  be  employed  for  all  UV-Vis 
measurements.  
The free ligand solution was analyzed by UV-Vis by varying the pH from 2.164 to 
11.611 by 0.1-0.2 pH units intervals. The base solution used for this purpose (0.1 M) 
had to be diluted when the pH was close to each pKA because otherwise a too big 
change in the absorbance value was observed even with very small additions of the 
titrant.  The  dilution  due  to  base  additions  was  taken  into  account  during  data 
evaluation. 
4.5.3  DQ58-Cu(II) solutions 
Two different experiments were carried out for DQ58-Cu(II) solutions. In the first 
experiment, two solutions were prepared, containing ligand-to-metal ratios 1:1 and 
1:0.5 ([L]0 = 0.081 mM and [M]0 = 0.066 mM, [L]0 = 0.081mM and [M]0 = 0.04 
mM,  respectively).  The  pH  was  varied  in  the  range  2.170-11.307  for  the  first 
solution,  and  2.171-11.613  for  the  second  one.  The  absorbance  spectra  were 
registered every 0.1-0.2 pH units. The second experiment was carried out to check 
the presence of the bis-complex (CuL2). A ligand solution (0.081 mM) was prepared, 
and the pH was set at ~6.1 by adding KOH 0.1 M. This intermediate pH was chosen 
in  order  to  favor  the  formation  of  the  bis-complex  without  causing  precipitate 
formation. The absorbance was registered in the absence of the metal, and for metal 
concentrations ranging from 0.007 mM to 0.064 mM, keeping constant the pH at 6.1 
± 0.1 by small additions of the base solution when necessary. The ligand dilution due 
to the additions was taken into account during data evaluation. 
Table 4.6 reports the Cu
2+ and KOH additions (the latter to keep the pH constant), 
the measured pH value, and the Cu
2+ concentration obtained in each experiment.  
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Table 4.6: Volumes, pH and concentrations of the UV-Vis measurements performed at constant 
pH and different ligand-to-metal ratios. The starting solution contained starting volume = 10 
mL, [DQ58]0=0.081 mM. 
Experiment 
n° 
Cu
2+ addition 
(μL) 
KOH addition 
(μL)  pH  Cu
2+ concentration 
(mmol/L) 
1  ---  ---  6.147  0 
2  40  ---  6.132  0.007 
3  40  15  6.145  0.014 
4  40  10  6.131  0.021 
5  40  13  6.125  0.028 
6  40  15  6.121  0.034 
7  40  15  6.139  0.041 
8  40  12  6.122  0.048 
9  40  12  6.107  0.054 
10  40  12  6.101  0.061 
11  40  10  6.122  0.064 
 
4.5.4  DQ71508 solutions 
Solutions containing DQ71508 only were prepared and analyzed in an analogous 
way  as  described  for  DQ58.  The  DQ71508  concentration  was  0.08  mM.  The 
measurements were carried out varying the pH from 2.190 to 9.242 by 0.1-0.2 pH 
units intervals.  
4.5.5  DQ71508-Cu(II) solutions 
As before, two different experiments were carried out for DQ71508-Cu(II) solutions. 
In the first experiment, two solutions containing [L]0 = 0.080 mM and [M]0 = 0.070 
mM, [L]0 = 0.080 mM and [M]0 = 0.040 mM, respectively, were prepared. The pH 
was varied in the range 2.203-9.318 for the first solution, and 2.207-7.230 for the 
second one. The absorbance spectra were registered  every 0.1-0.2 pH  units.  The 
second experiment was carried out starting from a 0.08 mM ligand solution added 
with  increasing  amounts  of  a  metal  solution  at  a  constant  pH  ~  6.1.  Metal 
concentrations ranged from 0.007 mM to 0.065 mM. 
Table 4.7 reports the Cu
2+ and KOH additions (the latter to keep the pH constant), 
the measured pH value, and the Cu
2+ concentration obtained in each experiment.  
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Table 4.7: Volumes, pH and concentrations of the UV-Vis measurements performed at constant 
pH and different ligand-to-metal ratios. The starting solution contained starting volume = 10 
mL, [DQ71508]0=0.08 mM. 
Experiment 
n° 
Cu
2+ addition 
(μL) 
KOH 
addition (μL)  pH  Cu
2+ concentration 
(mmol/L) 
1  ---  ---  6.181  0 
2  40  2  6.120  0.007 
3  40  15  6.143  0.014 
4  40  10  6.198  0.021 
5  40  10  6.143  0.028 
6  40  10  6.123  0.034 
7  40  10  6.125  0.041 
8  40  10  6.128  0.048 
9  40  10  6.121  0.054 
10  40  10  6.131  0.061 
11  20  ---  6.131  0.064 
 
 
4.6  EXPERIMENTAL PROCEDURE FOR 
1H-NMR SPECTROSCOPY 
1H NMR  studies  were carried out  on a  Bruker  DRX-400 which works  at  400.13 
MHz.  The  sample  temperature  was  set  at  298  K  during  all  data  acquisitions. 
Chemical  shifts  are  reported  in  ppm  (H)  from  Me3SiCH2CH2COOH 
(trimethylsilylpropionic  acid,  TMSP)  as  internal  reference.  The 
1H NMR 
measurements were performed through suppression of the water signal. Spectra were 
collected for all the three ligands  and for DQ71508-Zn(II), DQ58-Zn(II) and POA-
Al(III) solutions in D2O mixtures at 1.3 mM (DQ71508), 1.5 mM (DQ58) and 2.5 
mM (POA) ligand concentration.  
KCl was not added, and therefore the ionic strength is not constant for the different 
solutions, since an excessive electrolyte concentration does not allow to obtain a 
good  instrumental  homogeneity.  The  ligand  solutions  were  prepared  directly  by 
dissolving  the  solid  in  D2O.  The  solutions  containing  Zn(II)  or  Al(III)  and  each 
ligand were prepared by dissolving the appropriate amount of ligand in the solvent 
and adding respectively ZnO or AlCl3·6H2O solids in the correct stoichiometric ratio. 
The DQ71508– Zn(II) ratio is 1:2; the DQ58-Zn(II) ratio is 1:2 and the POA-Al(III) 
ratio is 4:1. Table 4.8 shows the concentrations of the solutions. 
  
 
65 
 
Table 4.8: species concentrations for 
1H-NMR solutions 
Solution 
DQ58 
(mmol/Kg
) 
DQ71508 
(mmol/Kg) 
POA 
(mmol/Kg) 
Zn(II) 
(mmol/Kg) 
Al(III) 
(mmol/Kg) 
DQ58  1.478  ---  ---  ---  --- 
DQ58-
Zn(II) 
1.478  ---  ---  2.866  --- 
DQ71508  ---  1.357  ---  ---  --- 
DQ71508-
Zn(II)  ---  1.357  ---  2.616  --- 
POA  ---  ---  2.525  ---  --- 
POA-
Al(III)  ---  ---  2.525  ---  0.650 
 
For  each  solution  listed  in  Table  4.8  three  aliquots  at  different  pH  values  were 
prepared (Table 4.9). The pH of the solutions was measured with a glass electrode 
(Crison) calibrated with two standard solutions at pH = 4 and pH = 7. The pH was 
adjusted by addition of small volumes of DCl 3 M and NaOD 2 M. The pH values 
given by the pH-meter has to be added by 0.41 logarithmic units, because of the 
isotopic effects due to the two different solvents used in the calibration (H2O) and in 
the measurements (D2O). The values obtained in this way, should be more correctly 
defined as  "pD",  since  they  represent the concentration of free acid D3O
+ in the 
heavy water solution; in the following, however, this magnitude will be indicated by 
the term "pH" for simplicity. 
 
Table 4.9: pH values for 
1H-NMR measurements 
  pH of solution 1  pH of solution 2  pH of solution 3 
DQ58  2.54  3.88  6.36 
DQ58-Zn(II)  ---  3.90  6.34 
DQ71508  3.23  5.24  6.36 
DQ71508-Zn(II)  3.17  ---  6.43 
POA  2.76  4.22  5.16 
POA-Al(III)  2.65  4.22  5.17 
 
 
  
 
66 
 
4.7  EXPERIMENTAL PROCEDURE FOR EPR MEASUREMENTS  
All CW-EPR spectra were recorded with a BRUKER EleXsys E500 spectrometer 
(microwave frequency ~9.7 GHz, microwave power 13 mW, modulation amplitude 5 
G,  modulation  frequency  100  kHz).  The  isotropic  EPR  spectra  were  recorded  at 
room temperature in a circulating system during a titration. Three EPR spectra were 
recorded at 0.4 mM CuCl2 and 1.3 mM DQ71508 ligand concentration, in the pH 
range  1.8-3.8.  At  higher  pH  values  precipitation  was  detected.  The  0.2  M  ionic 
strength was adjusted with KCl. The solution pH was changed by KOH (2 M) or HCl 
(1 M) additions, and it was registered with an Orion 710A pH-meter equipped with a 
Metrohm 6.0234.100 glass electrode. A Heidolph Pumpdrive 5101 peristaltic pump 
was used to circulate the solution from the titration pot through a capillary tube into 
the  cavity  of  the  instrument.  The  titrations  were  carried  out  under  nitrogen 
atmosphere. At various pH values, samples of 100 μL were taken from each solution 
and frozen in liquid nitrogen, to perform isotropic CW-EPR spectra. These were 
recorded under the same instrumental conditions as the room-temperature spectra 
described above. Table 4.10 schematizes the procedure. 
 
Table 4.10: additions and withdrawal during EPR experiment; registered pH values before and 
after the acquisition of the spectra 
Solution n°  VKOH (mL)  VHCl (mL)  Withdraw (mL)  pH 
1  ---  ---  ---  1.84 
2  0.16  0.1  0.1  3.05 
3  0.14  ---  0.1  3.78 
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5  pH-POTENTIOMETRIC RESULTS AND 
DISCUSSION 
 
 
5.1  KOH STANDARDIZATION 
KOH  solutions  were  standardized  against  hydrogen  potassium  phthalate.  The 
equivalence point in these titrations was obtained with the best accuracy by using the 
Gran method (Gran plot) [Maccà 1995], which also gives an estimation of the KOH 
carbonate content from the different points of intersection of the Gran-plots at acidic 
and at basic pH (max. ~ 0.5 - 0.8 % of carbonate over base content was accepted). 
The concentrations of the KOH solutions used in this thesis are listed in Table 5.1. 
 
Table 5.1: concentration values of KOH solutions used for the different systems investigated 
System  KOH concentration (mol/L) 
DQ58 + DQ58-Zn(II)  0.0928 ± 0.0003 
DQ71508 + DQ71508-Zn(II)/Cu(II)  0.0998 ± 0.0002 
POA + POA-Zn(II)/Al(III)  0.1185 ± 0.0002 
 
 
 
5.2  HCl-KOH TITRATIONS 
The exact concentration of the strong acid (HCl) solution, the Irving factor (IRV) and 
water ionization constant (pKw) were determined by these titrations. The equivalence 
volume was obtained by the Gran method. The Irving factor (5.1) was calculated by 
subtracting the calculated pH values of the strong acid-strong base titration curve 
(computed from the known concentrations and volumes) from the measured values at 
pH < 3, when the pH contribution of water is completely negligible. 
 
IRV = ∆pH = pHmeasured − pHcalculated            (5.1) 
 
After  the  equivalence  point,  the  pOH  values  can  be  calculated  from  the  known 
concentrations and volumes, after correction with the Irving factor. Thus, pKw is 
calculated from the data obtained in the alkaline pH range (5.2): 
 
pKw = −log([H
+][OH
−]) = pH + pOH = (pHmeasured − IRV) − log[OH
−]  (5.2)  
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pKw depends on the temperature and the ionic strength. The water ionization constant 
pKw under the conditions employed (25 °C, 0.20 M (KCl)) was 13.76 ± 0.02. When 
the experimental value of pKw differed, the sensitivity (or slope) of the electrode has 
to be changed. The apparent E
0 value of the glass electrode was determined through 
calibration with a 0.05 M potassium hydrogen phthalate solution (pH = 4.008 at 25 
°C). The electrode was calibrated before each strong acid-strong base titration.  
The HCl concentration detected was 0.228 ± 0.001 mol/L. 
 
 
5.3  LIGAND TITRATIONS 
5.3.1  DQ58 
Potentiometric titration of each ligand allowed the determination of the pKA values, 
which  are  reported  in  Table  5.2.  The  pKA1  could  not  be  determined  by  pH-
potentiometric titrations, because it is too low. For other hydroxypyridinecarboxylic 
acids (HPCs) the pKA1 values were determined by UV-Vis [Crisponi 2012 (b)] and 
resulted to be below 1. In any case, the pKA1 value is unimportant as it does neither 
affect the ligand equilibrium at physiological conditions, nor does it influence the 
metal-ligand complex stability unless at extremely acidic pH values.  
The deprotonation  process  of DQ58 is in  principle relatively complicated, as  the 
aromatic form of the ligand may coexist with the chinoid one, and each forms is in 
tautomeric equilibrium with the other. As result, many species can form at any pH 
value. However, data available till now suggest that the HPCs tautomeric keto-enolic 
equilibrium in aqueous solution is shifted towards the aromatic form [Crisponi 2012 
(b)], and the exclusive formation of aromatic deprotonation products can be assumed 
for simplicity. Under this hypothesis, the pKA1 and pKA2 values can be attributed to 
the deprotonation of the two carboxylic groups, which are intrinsically more acidic 
than pyridinium and phenol. Among the latter two acidic groups, pyridinium has an 
intrinsic  pKA  of  ca.  5  and  phenol  of  ca.  9.  Furthermore,  when  one  (or  both) 
carboxylic groups deprotonate, an intramolecular hydrogen bond is formed between 
one carboxylate and the phenolic hydrogen. The stabilization induced by this bond 
not only lowers the pKA1 and pKA2 values, but also it is expected to decrease the 
acidic properties of phenol. Therefore, pKA3 can be attributed to pyridinium, and 
pKA4  to  phenol.  The  possible  processing  of  deprotonation  in  DQ58  is  shown  in 
Figure 5.1. 
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Figure 5.1: proposed deprotonation sequence of DQ58  
 
5.3.2  DQ71508 
pKA values of DQ71508 are reported in Table 5.2.  
The deprotonation sequence of this ligand is more sure than for DQ58, as no chinoid 
species can form. Similar considerations as for DQ58 can be done for the pKA values 
of this ligand, except that no pyridinium deprotonation can be observed. The last 
proton is lost at pH~6.8 and belongs to the phenolic group. The significantly higher 
acidity of the phenolic group in DQ71508 with respect to DQ58 is due to the positive 
charge on nitrogen, which favours the deprotonation process. Similar phenolic pKA 
values have been observed for all other 1-methylated HPC studied so far [Crisponi 
2012 (b)]. The proposed deprotonation process is shown in Figure 5.2. 
 
 
Figure 5.2: proposed deprotonation sequence of DQ71508 
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Finally, it is possible to state that the medium has a small but not negligible effect on 
the acidity of both ligands: when comparing the pKA values detected in this work 
with those obtained in previous theses [Cassini 2012, Feltracco 2013], which have 
been measured in NaCl 0.6 mol/kg, it can be concluded that pKA values decrease by 
~0.3 log units upon increasing the ionic strength from 0.2 mol/L KCl to 0.6 mol/Kg 
NaCl. 
5.3.3  POA 
pKA values of POA are reported in Table 5.2.  
Like for DQ71508, also for this ligand no tautomeric equilibrium can occur, so that 
the deprotonation sequence of POA is rather certain and it is shown in Figure 5.3. 
The loss of the first proton is not detectable since it occurs at very low pH (< 1). The 
second proton to be lost belongs to the nitrogen and this deprotonation occurs at pH 
~ 5. The last proton is lost at pH~9.8 and belongs to the phenolic group. pKA values 
agree with those reported for other 3-hydroxy-4-pyridinecarboxylic acids studied so 
far [Crisponi 2012 (b)]. 
 
 
 
Figure 5.3: proposed deprotonation sequence of POA 
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Table 5.2: pKA and logβ values (uncertainty*) of DQ58, DQ71508 and POA at 25 °C in aqueous 
KCl 0.2 mol/L 
Stability constants  DQ58  DQ71508  POA 
pKA1  ---  ---  --- 
pKA2  3.25 (2)  3.16 (6)  5.34 (3) 
pKA3  6.39 (1)  6.83 (2)  9.82 (2) 
pKA4  11.04 (1)  ---  --- 
logβHL  11.04 (1)  6.83 (2)  9.82 (2) 
logβH2L  17.43 (1)  9.99 (6)  15.16 (2) 
logβH3L  20.68 (2)  ---  --- 
logβH4L  ---  ---  --- 
* Three times the standard deviation 
 
 
 
5.4  METAL-LIGAND COMPLEXES 
5.4.1  DQ58-Zn(II) complexes 
Solutions containing DQ58 and Zn(II) show the presence of only one complex, the 
neutral species having stoichiometry ZnLH (for the definition of "L" see caption of 
Figure 5.1). The stability constant of ZnLH, defined as seen in chapter 3 (equation 
3.3), is reported in Table 5.3. The pH-potentiometric titration curves measured at 
1:0.87 and 1:0.48 ligand-to-metal concentration ratios, and the species-distribution 
diagram for a typical DQ58-Zn(II) solution, are depicted in Figure 5.4.  
  
 
Figure 5.4: Left: pH-metric titration curves for DQ58-Zn(II) solutions ([DQ58]0=1.00•10
−3 M 
and [Zn
2+]0=8.75•10
−4 M or 4.86•10
−4 M, respectively). Right: distribution diagram for a DQ58-
Zn(II) solution ([DQ58]0=1.00•10
−3 M; [Zn
2+]0=4.90•10
−4 M; charges are omitted for simplicity). 
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Complex formation starts at pH ~ 4. In the presence of the metal ion, slight changes 
in the titration curves were observed. A sharp break on the titration curves occurs at 
pH~5.8-6.5  (depending  on  the  ligand-to-metal  ratio)  as  shown  in  the  distribution 
diagram  in  the  correspondence  of  the  dashed  vertical  line.  The  solid  which 
precipitates at this pH range is probably not the metal hydroxide (Zn(OH)2 should 
precipitate at pH > 7). According to the potentiometric results, the solid might be 
ZnLH reaching its solubility limit, or it can be the bis-complex ZnL2, which was not 
detected in solution and therefore should be assumed to have a very low solubility in 
water. The pH precipitation values listed in chapter 4 (paragraph 4.4.6) appear to be 
positively  correlated  with  the  metal  concentration  rather  than  with  the  ligand-to-
metal  ratio.  Therefore,  the  precipitate  is  more  likely  ZnLH,  and  in  this  case  its 
solubility is about 4·10
–4 M.  
 
Table 5.3: stability constants of the DQ58-Zn(II) complexes as from potentiometric 
measurements at 25 °C in aqueous KCl 0.2 mol/L  
Complex  logβ (uncertainty*) 
ZnLH  15.09 (3) 
* Three times the standard deviation 
 
5.4.2  DQ71508-Zn(II) complexes  
The  elaboration  of  potentiometric  titration  data  allowed  the  identification  of  two 
metal-ligand complexes, the protonated, charged ZnLH
+ and the neutral ZnL (for the 
definition of "L" see caption of Figure 5.2). The stability constants are reported in 
Table 5.4. 
pH-potentiometric  titration  curves  measured  at  1:0.9,  2:1  and  4:1  ligand-to-metal  
concentration  ratios  and  the  species-distribution  diagram  for  a  typical  DQ71508-
Zn(II) solution are depicted in Figure 5.5. 
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Figure 5.5: Left: pH-metric titration curve for DQ71508-Zn(II) solutions ([DQ71508]0=1.50•10
−3 
M and [Zn
2+]0=3.90•10
−4 M, 7.70•10
−4 M or 1.34•10
−3 M, respectively). Right: distribution 
diagram for a DQ71508-Zn(II) solution ([DQ71508] 0=1.51•10
−3 M; [Zn
2+]0=3.87•10
−4 M; charges 
are omitted for simplicity). 
 
Complex formation starts at pH~3. In the presence of the metal ion, modest changes 
of the titration curves were observed. Two deprotonation steps are still observed on 
the titration curves, that means that there is free ligand in the solution, and indicating 
that the complexes are not very stable. The sharp break on the titration curve at 
ligand excess indicates that a precipitation process occurs at pH~8. The pH at which 
the  precipitation  occurs,  the  positive  correlation  of  the  precipitation  pH  and  the 
ligand-to-metal ratio (see paragraph 4.4.7), and the appearance of the precipitate, all 
suggest that the solid is the metal hydroxide Zn(OH)2. 
 
Table 5.4:  stability constants of DQ71508-Zn(II) complex as from potentiometric measurements 
at 25 °C in aqueous KCl 0.2 mol/L 
Complex  logβ (uncertainty*) 
ZnLH
+  9.25 (6) 
ZnL  4.59 (6) 
* Three times the standard deviation 
The pKA of ZnLH
+ can be computed from the difference between the log values of 
ZnLH
+  and  ZnL,  and  it  results  to  be  4.66.  This  should  correspond  to  the 
deprotonation of the unbound carboxylate, which for the free ligand has a pKA of 
3.16. The larger value for the complex may be due to a more pronounced electron-
donating  effect  of  aquo-Zn
2+  with  respect  to  the  proton,  which  destabilizes  the 
deprotonated form; this electron-donation by Zn
2+ is evident also from NMR spectra, 
see below.  
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5.4.3  DQ71508-Cu(II) complexes 
The elaboration of potentiometric titration data allowed the identification of the same 
two metal-ligand complexes as observed for DQ71508-Zn(II), i.e. CuLH
+ and CuL. 
The stability constants of these complexes are reported in Table 5.5. 
pH-potentiometric  titration  curves  measured  at  1:0.9,  2:1  and  4:1  ligand-to-metal 
concentration ratios, and a typical species distribution diagram for DQ71508-Cu(II), 
are depicted in Figure 5.6.  
 
Figure 5.6: Left: pH-metric titration curves for DQ71508-Cu(II) solutions 
([DQ71508]0=1.298•10
−3 M and [Cu
2+]0=3.60•10
−4 M, 7.20•10
−4 M or 1.29•10
−3 M). Right: 
distribution diagram for a DQ71508-Cu(II) solution ([DQ71508]0=1.30•10
−3 M; 
[Cu
2+]0=3.30•10
−4 M; charges are omitted for simplicity). 
 
Complex formation starts at pH < 3 as it is clear both from the titration curves and 
the distribution diagrams. As just little differences are observed between the titration 
curves  in  the  absence  and  in  the  presence  of  the  metal  ion,  complexes  that  are 
forming are weak. The sharp break on the titration curve at ligand excess indicates 
occurs at a very low pH (3 < pH < 4), which is positively correlated with the metal 
concentration rather than with the ligand-to-metal ratio. The solid precipitating in 
this pH range is probably not the metal hydroxide (Cu(OH)2 should precipitate at pH 
> 6), and could therefore be assigned to the neutral complex CuL. 
 
Table 5.5: stability constants of the DQ71508-Cu(II) complex as from potentiometric 
measurements at 25 °C in aqueous KCl 0.2 mol/L 
Complex  logβ (uncertainty*) 
CuLH
+  10.02 (1) 
CuL  7.26 (3) 
* Three times the standard deviation 
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5.4.4  POA-Zn(II) complexes  
The elaboration of potentiometric titration data did not allow the identification of any 
metal-ligand complexes. This was due to their extreme weakness, which is evident 
also from the pH-potentiometric titration curves measured at various ligand-to-metal 
concentration ratios depicted in Figure 5.7, which are very similar to the curves in 
the absence of metal ion. The sharp break on the titration curve at ligand excess 
indicates  that  a  precipitation  process  occurs  at  pH~7.5.  The  pH  at  which  the 
precipitation occurs and the appearance of the precipitate suggest that it is the metal 
hydroxide Zn(OH)2.  
 
Figure 5.7: pH-metric titration curves for POA-Zn(II) solutions ([POA]0=1.99•10
−3 M and 
[Zn
2+]0=4.98•10
−4 M, 8.95•10
−4 M or 1.79•10
−3 M, respectively) 
 
5.4.5  POA-Al(III) complexes 
The  elaboration  of  potentiometric  titration  data  allowed  the  identification  of  a 
considerably large number of metal-ligand complexes with general metal-to-ligand 
stoichiometry  1:1,  1:2  and  1:3  and  with  different  protonation  states.  The 
stoichiometry and the stability constants of these complexes are reported in Table 
5.6.  pH-potentiometric  titration  curves  measured  at  various  ligand-to-metal 
concentration  ratios,  and  a  typical  species  distribution  diagram  for  Al(III)-POA 
solutions, are depicted in Figure 5.8 and Figure 5.9, respectively.  
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Figure 5.8: pH-metric titration curves for POA-Al(III) solutions ([POA]0=1.858•10
−3 M and 
[Al
3+]0=5.05•10
−4 M, 1.01•10
−3 M or 1.81•10
−3 M, respectively) 
 
Complex formation starts at pH~2.5. The titration curves in the presence of the metal 
ion differ considerably from those of the free ligand, thus indicating that relatively 
strong complexes are formed. This is due to the hard character of the metal ion Al
3+, 
which  has  a  large  affinity  towards  the  carboxylate  and  phenolate  coordinating 
groups. 
 
Figure 5.9: Distribution diagram for a POA-Al(III) solution ([POA]0=2.50•10
−3 M and 
[Cu
2+]0=0.65•10
−3 M; charges are omitted for simplicity). 
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The distribution diagram in Figure 5.9 shows that the free metal ion is present only at 
very acidic pH. By increasing the pH, the main complexes AlLH
2+, AlL2H2
+ and 
AlL3
3– are forming. Many other minor species are formed in solution, especially at 
neutral pH, resulting from the deprotonation of the mono and bis-complexes and 
from the protonation of AlL3
3–. While for the complex AlL3H3 the deprotonation 
must occur at the pyridinic nitrogen, in AlL2H2 it can occur more probably at the 
coordinating water. In fact, the pKA relative to the loss of the pyridinic proton in free 
ligand is 6.20, and it is almost one order of magnitude higher than the pKA of the 
hexa-aquoion hydrolysis, which is 5.52. 
The  precipitation  of  the  aluminium  hydroxide  is  not  observed  if  solutions  at 
sufficiently high ligand-to-metal ratios are titrated. At very basic pH values the POA-
Al(III) complexes are destabilized due to the formation of the tetrahydroxoaluminate 
ion, Al(OH)4
−. Such behavior at basic pH is always observed in Al(III) solutions 
containing any kind of ligand. 
 
Table 5.6: stability constants of POA-Al(III) complexes as from potentiometric measurements at 
25 °C in aqueous KCl 0.2 mol/L 
Complex  logβ (uncertainty*) 
AlLH
2+  9.56 (5) 
AlL
+  15.10 (2) 
AlL2H2
+  16.2 (4) 
AlL2H  23.3 (3) 
AlL2
−  29.46 (2) 
AlL3H3  22.33 (6) 
AlL3H2
−  28.91 (3) 
AlL3H
2−  36.05 (2) 
AlL3
3−  41.76 (3) 
* Three times the standard deviation 
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6  SPECTROSCOPIC RESULTS AND DISCUSSION 
 
 
6.1  UV-VIS MEASUREMENTS 
Spectrophotometric  measurements  were  performed  both  to  confirm  the 
potentiometric data, and to investigate the possible presence of additional complexes 
not determined by pH-potentiometric measurements. It was possible to obtain the 
ligand protonation  constants,  and the overall stability constants  of the complexes 
detected in the solutions. 
6.1.1  Solutions containing DQ58 
The recorded spectra are shown in Figure 6.1 (from pH 2.164 to 3.656), Figure 6.2 
(from pH 5.836 to 7.751), and Figure 6.3 (from pH 10.179 to 11.399). These pH 
ranges have been chosen according to potentiometric results, in order to show the 
presence  of  isosbestic  points  due  to  the  presence  of  a  pKA.  An  isosbestic  point 
indicates the coexistence of two species in equilibrium, which in these cases are H3L-
H2L,  H2L-HL  and  HL-L,  respectively  (charges  are  omitted  for  simplicity).  The 
absorption bands in the spectra are attributed to the n → π * electronic transitions of 
the carboxylic groups and to the π → π * transitions of the aromatic ring. 
 
 
Figure 6.1: UV-Vis spectra of DQ58 ([DQ58]0=0.08 mM) in KCl 0.2 M, registered from pH 2.164 
to 3.656 with a 1 cm path length.   
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Figure 6.2: UV-Vis spectra of DQ58 ([DQ58]0=0.08 mM) in KCl 0.2 M, registered from pH 5.836 
to 7.751 with a 1 cm path length.  
 
 
 
 
Figure 6.3: UV-Vis spectra of DQ58 ([DQ58]0=0.08 mM) in KCl 0.2 M, registered from pH 
10.179 to 11.399 with a 1 cm path length.  
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UV data have been processed at λ = 248, 264, and 304 nm,  i.e. at the wavelengths 
where the absorption differences between the species present in solution are maxima. 
It was chosen not to evaluate the spectra at 224 nm and 210 nm, despite significant 
changes  are  observed  by  varying  the  pH,  because  at  these  wavelengths  the 
absorbance  values  are  too  high  and  therefore  not  accurate.  Ligand  protonation 
constants  obtained  from  the  spectra  elaborations  are  reported  in  Table  6.1;  for 
comparison  purposes,  the  potentiometric  values  are  reported  as  well.  It  can  be 
noticed  that  UV-Vis-derived  logβ  values  agree  well  with  the  corresponding 
potentiometric ones.  Molar absorptivities  of the ligand at  wavelengths  of interest 
were determined also, and are reported in Table 6.2.  
 
Table 6.1: logβ (uncertainty) of DQ58 obtained by both potentiometric and spectrophotometric 
techniques 
  pH-pot  UV-Vis 
H3L  20.68 (2)  20.85 (2) 
H2L  17.43 (1)  17.62 (3) 
HL  11.04 (1)  11.01 (2) 
 
 
Table 6.2: molar absorptivities ε (uncertainty) of DQ58 at specific wavelengths  
Wavelength 
(nm) 
εH3L 
(mol
−1·L·cm
−1) 
εH2L 
(mol
−1·L·cm
−1) 
εHL 
(mol
−1·L·cm
−1) 
εL 
(mol
−1·L·cm
−1) 
248  6740 ± 43  6558 ± 39  3622 ± 35  7125 ± 38 
264  1423 ± 22  3922 ± 30  4699 ± 49  3456 ± 41 
304  5956 ± 47  2148 ± 37  1059 ± 21  4055 ± 45 
 
6.1.2  Solutions containing DQ58+Cu(II) 
The  complexation  equilibria  between  DQ58  and  Cu(II)  has  been  studied  by  pH-
potentiometric measurements in the frame of a different thesis work [Suba 2013]. 
Since precipitation occurred at pH < 3, it has been possible to detect with a good 
accuracy  only  the  monocomplex  CuLH
+  (logβ  =  17.6  (3)).  Therefore, 
spectrophotometric measurements on this system have been carried out, in order to 
clarify the metal coordination also at higher pH values. This was possible because at 
the lower concentrations explored by UV-Vis no precipitation was observed. 
Figure 6.4 shows the spectra recorded for DQ58:Cu(II) solutions at a ligand-to-metal 
concentration ratio of 1:1. These spectra are different from those of the free ligand, 
as new absorption bands are visible: this is an indication of the complexes formation.  
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Furthermore, the main peak at 248 nm is due to pyridinic ring π → π* transitions, 
and  by  increasing  the  pH  from  pH=2.17  to  pH=6.10  the  deprotonation  causes  a 
bathochromic shift till around 252 nm.  
 
 
Figure 6.4: UV-Vis spectra of DQ58-Cu(II) solutions ([DQ58]0=0.08 mM; [Cu
2+]0=0.066 mM) in 
KCl 0.2 M, registered from pH 2.170 to 11.307 with a 1 cm path length.  
 
Together with the spectra at the same ligand and metal concentrations, and different 
pH values, other spectra were recorder where the pH was kept constant and the metal 
was added to a ligand solution. Figure 6.5 shows the absorption spectra of the these 
solutions,  whereas  Figure  6.6  reports  the  graph  Abs/[DQ58]0  vs.  [Cu]0/[DQ58]0. 
According to the latter graph, the bis-complex might be present in solution, because a 
slight slope change in the curve can be observed at [Cu]0/[DQ58]0 = 0.5. For more 
sure conclusions, and in order to obtain the stability constants of the complexes, the 
UV-Vis  data  have  to  be  elaborated  by  PSEQUAD  or  by  HYPERQUAD.  These 
elaborations, anyway, are still in progress. 
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Figure 6.5: absorption spectra of DQ58-Cu(II) solutions obtained by increasing the Cu
2+ 
concentration. See Table 4.6 for experimental details. 
 
 
 
Figure 6.6: : A·1000/[DQ58]0 vs. [Cu]0/[DQ58]0 calculated for each solution examined (dilutions 
have been taken into account) 
 
6.1.3  Solutions containing DQ71508 
The UV-Vis spectra of DQ71508 solutions are shown in Figure 6.7 (from pH 2.765 
to  5.013),  and  Figure  6.8  (from  pH  5.013  to  8.789).  These  pH  range  have  been 
chosen  (as  for  DQ58)  according  to  potentiometric  results  in  order  to  show  the  
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presence  of  isosbestic  points  and  therefore  confirm  the  equilibrium  between  two 
differently protonated forms of the ligand at pH around each pKA values.  
 
Figure 6.7: UV-Vis spectra of DQ71508 ([DQ71508]0=0.08 mM) in KCl 0.2 M, registered from 
pH 2.765 to 5.013 with a 1 cm path length. 
 
 
 
 
 
 
Figure 6.8: UV-Vis spectra of DQ71508 ([DQ71508]0=0.08 mM) in KCl 0.2 M, registered from 
pH 5.013 to 8.789 with a 1 cm path length.  
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UV data have been processed at λ = 250, 268, and 316 nm, i.e. at the wavelengths 
that maximize the absorption differences between the species present in solution. 
Ligand protonation constants obtained from spectra evaluation are reported in Table 
6.3 together with the corresponding potentiometric data. It can be observed that the 
correspondence between values obtained by the two techniques is excellent, and it is 
within  the  experimental  uncertainty.  Molar  absorptivities  of  the  ligand  at 
wavelengths of interest were determined also, and are reported in Table 6.4. 
 
 
Table 6.3: logβ (uncertainty) of DQ71508 obtained by both potentiometric and 
spectrophotometric techniques 
  pH-pot  Uv-Vis 
H2L  9.99 (6)  9.95 (1) 
HL  6.83 (2)  6.79 (1) 
 
 
Table 6.4: molar absorptivities ε (uncertainty) of DQ71508 at specific wavelengths 
Wavelength 
(nm) 
εH2L (mol
−1·L·cm
−1)  εHL (mol
−1·L·cm
−1)  εL (mol
−1·L·cm
−1) 
250  6988 ± 43  6216 ± 41  4552 ± 38 
268  1329 ± 23  3915 ± 33  10617 ± 49 
316  4411 ± 28  1436 ± 17  813 ± 15 
 
6.1.4  Solutions containing DQ71508+Cu(II) 
Figure 6.9 shows the spectra recorded for DQ71508:Cu(II) solutions at a ligand-to-
metal ratio of 1:1 and at various pH value. The peak which experience the maximum 
variation  with  pH  is  the  one  which  at  pH  2.2  resonates  at  254  nm.  It  is  due to 
pyridinic ring π → π* transitions, and by increasing the pH the deprotonation causes 
a bathochromic shift till around 268 nm. 
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Figure 6.9: UV-Vis spectra of DQ71508-Cu(II) solutions ([DQ71508]0=0.08 mM; [Cu
2+]0=0.07 
mM) in KCl 0.2 M, registered from pH 2.203 to 9.318 with a 1 cm path length. 
 
As for DQ58-Cu(II), also for DQ71508-Cu(II) solutions other spectra were recorder 
where the pH was kept constant and the metal was added to a ligand solution. Figure 
6.10 shows the absorption spectra of the these solutions (pH is kept constant at the 
value  6.10  ±  0.09),  and  Figure  6.11  reports  the  graph  Abs/[DQ71508]0  vs. 
[Cu]0/[DQ71508]0.  It  appears  that  the  DQ71508-Cu(II)  bis-complex  might  form, 
because a slight slope change in the curve can be observed at [Cu]0/[DQ71508]0 = 
0.5.  Here  too,  however,  no  definite  conclusions  can  be  drawn,  and  no  stability 
constants of the complexes could be obtained up to now, because the UV-Vis data 
have not been elaborated yet.  
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Figure 6.10: absorption spectra of DQ71508-Cu(II) solutions obtained by increasing the Cu
2+ 
concentration.   
 
 
Figure 6.11: A·1000/[DQ71508]0 vs. [Cu]/[DQ71508]0 calculated for each solution examined 
(dilutions have been taken into account)  
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6.2  NMR MEASUREMENTS 
6.2.1  Solutions containing DQ58 and DQ58+Zn(II) 
Figure  6.12  shows the 
1H-NMR  spectra of DQ58  solutions at  three different  pH 
values. These spectra show a single peak representative of the two equivalent protons 
in position 2 and 6 of the pyridine ring: only one peak is observed as the ligand is 
symmetric (see Figure 2.4). As expected, no signals belonging to the carboxylic, 
phenolic and pyridinic protons are observed, as they exchange very quickly with the 
protons of the water. By increasing the pH, there is a shift of the aromatic signal at 
higher  fields,  due  to  the  gradual  de-protonation  of  the  acidic  groups  of  DQ58 
(according to the pKA values reported in Table 5.2). In the spectrum recorded at more 
basic pH (spectrum c) there is a slight enlargement of the peak. This broadening may 
indicate the coexistence of more ligand forms at equilibrium. For DQ58, the most 
probable forms at equilibrium are the aromatic and the chinoid tautomeric forms. 
Therefore, the NMR indicate that for DQ58 the chinoid form can be more important, 
at  least  at  pH  larger  than  6,  than  for  the  other  HPCs  investigated  so  far.  NMR 
measurements at different frequency and/or temperature might permit to obtain more 
information about the kinetics and perhaps also the thermodynamics of the keto-
enolic equilibrium for DQ58. 
 
Figure 6.12:
 1H–NMR spectra for DQ58 (1.478·10
–3 m) at different pH values: a) pH = 2.54; 
b) pH = 3.88; c) pH = 6.36 in D2O. Only the region of interest (the aromatic one between 8.3 and 
9.2 ppm) is shown in the spectra. 
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1H–NMR spectra of Zn(II)+DQ58 solutions at different pH values are reported in 
Figure 6.13. In both spectra, the main signal can be attributed to both the free ligand 
and the monocomplex ZnLH
+, since they are expected to exchange very quickly and 
therefore they should give rise to only one signal, the position of which is a weighted 
mean value between the chemical shift of the free ligand and that of the complex; the 
mean is weighted on the concentration.  
Additional  minor peaks  are detected in  the spectra, especially  at  more basic pH, 
indicating the formation of additional inert species in solution. This finding does not 
agree  with  the  potentiometric  results,  which  indicate  the  formation  of  only  one 
complex.  Therefore,  the  latter  data  should  be  reconsidered,  and/or  NMR  spectra 
should be repeated. 
 
Figure 6.13:
 1H–NMR spectra for DQ58-Zn(II) ([DQ58]0=1.478·10
–3 m; [Zn
2+]0=2.866·10
–3 m) at 
different pH values: a) pH = 3.90; b) pH = 6.34 in D2O. Only the region of interest (the aromatic 
one between 8.2 and 9 ppm) is shown in the spectra. 
 
6.2.2  Solutions containing DQ71508 and DQ71508+Zn(II) 
Figure 6.14 shows the 
1H-NMR spectra of DQ71508 solutions at three different pH 
values. In the aromatic area a single peak can be observed, which is attributed to the 
two equivalent protons in position 2 and 6 of the pyridine ring, as seen for DQ58. In 
the aliphatic region (not shown), another singlet appears (e.g. at 4.03 ppm for the 
solution at pH = 3.23), which is attributed to the 1-methyl protons.  
By increasing the pH, a shift of both the aromatic and aliphatic protons towards 
lower ppm values is observed. This is caused by the increasing shielding due to the  
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progressive deprotonation of the acidic groups of DQ71508. This shift is much less 
pronounced  for  the  signal  of  the  methyl  since  it  is  less  affected  by  acid-base 
equilibrium than are the aromatic protons. 
 
 
Figure 6.14: 
1H–NMR spectra for DQ71508 (1.357·10
–3 m) at different pH values: a) pH = 3.23; 
b) pH = 5.24; c) pH = 6.36 in D2O. Only the region of interest (the aromatic one between 8.2 and 
8.9 ppm) is shown in the spectra. 
 
 
1H–NMR spectra of Zn(II)+DQ71508 solutions at different pH values are reported in 
Figure  6.15.  As  for  DQ58,  the  main  signal  is  an  average  weighted  mean  of  the 
signals of the free ligand and of the complexes. In the spectrum registered at more 
acidic pH, the signal has the same chemical shift (8.74 ppm) as the free ligand at the 
same pH: this fact indicate the absence of complex formation, and agrees with the 
potentiometric results. In the spectrum at pH=6.43 the average signal is shifted up-
field with respect to that of the free ligand at the same pH, indicating that Zn
2+ has a 
more electrondonating effect  than the proton.  This  evidence is  coherent  with  the 
finding that the carboxylate pKA of the free ligand is lower than that of the complex, 
and  was  observed  also  for  DQ58-Zn
2+  complexes.  Differently  than  for  DQ58, 
however, for DQ71508 no additional signals are observed in the spectra, i.e. the 
speciation obtained by NMR and by potentiometric titrations appear to be coherent in 
this case. 
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Figure 6.15:
 1H–NMR spectra for DQ71508-Zn(II) ([DQ71508] 0=1.357·10
–3 m; [Zn
2+]0=2.616·10
–
3 m) at different pH values: a) pH = 3.17; b) pH = 6.43 in D2O. Only the region of interest (the 
aromatic one between 8.2 and 8.9 ppm) is shown in the spectra. 
 
 
6.2.3  Solutions containing POA and POA+Al(III) 
Figure  6.16  shows  the 
1H-NMR  spectra  of  POA  solutions  at  three  different  pH 
values. The aromatic region of these spectra shows a single peak representative of 
the proton in position 6 in the pyridine ring (see Figure 2.4). Peaks are very narrow 
(the apparent broadness of the peaks in Figure 6.16 is due to the enlarged ppm scale). 
The aliphatic region (not shown) displays the singlets of the methyl group in position 
2 (e.g. at 2.69 ppm for the solution at pH = 2.76) and of the methylenic group in 
position 5 (e.g. at 5.02 ppm for the solution at pH = 2.76).  
By increasing the pH, there is a shift of all signals towards higher fields, due to the 
gradual  de-protonation  of  the  two  acidic  groups  of  POA.  The  chemical  shift 
difference between spectra a) and b) is very low since there is no deprotonation in 
this pH range (2.76-4.22). The chemical shift difference for aliphatic protons is very 
small at all the investigated pH values, as these protons are only marginally affected 
by deprotonation of carboxylate, pyridinium and phenol. 
  
 
92 
 
 
Figure 6.16:
 1H–NMR spectra for POA (2.525·10
–3 m) at different pH values: a) pH = 2.76; 
b) pH = 4.22; c) pH = 5.16 in D2O. Only the region of interest (the aromatic one between 7.9 and 
8.2 ppm) is shown in the spectra. 
 
 
1H–NMR spectra of Al(III)+POA solutions at different pH values are reported in 
Figure 6.17. In each spectra, the most intense signal is attributed to the free ligand, 
because the chemical shift corresponds to that observed in the spectra of the free 
ligand (Figure 6.16). At the most acidic pH, a small additional peak can be detected 
together with that of the free ligand. At this pH, the main species expected in solution 
beside  the  free  ligand  is  the  complex  AlLH
2+,  as  indicated  by  the  distribution 
diagram of Figure 5.9. This new signal should therefore be attributed to this species. 
As seen for Zn(II), here too the complex signal is shifted up-field with respect to the 
free ligand peak, indicating a more pronounced electron-donating effect (or a minor 
electron-attracting effect) of aquo-Al
3+ with respect to the proton. In the spectrum b) 
a new broad peak appears close to that of AlLH
2+: this indicates that at least one new 
complex is forming. From the distribution diagram of Figure 5.9, the new signal can 
be supposed to  be AlL2H2
+.  In the spectrum  c), collected at  more basic pH, the 
disappearance of the AlLH
2+ signal can be observed. This data is coherent with the 
potentiometric results, which indicate that AlLH
2+ should be negligible at pH larger 
than ca. 5. In the place of this signal, two other signals can be observed, which 
cannot be attributed easily as many species coexist in solution at these conditions.  
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Figure 6.17:
 1H–NMR spectra for POA-Al(III) ([POA]0=2.525·10
–3 m; [Al
3+]0=0.650·10
–3 m) at 
different pH values: a) pH = 2.65; b) pH = 4.22; c) pH = 5.17 in D2O. Only the region of interest 
(the aromatic one between 7.8 and 8.2 ppm) is shown in the spectra. 
 
The  integration  values  of  the  NMR  aromatic  signals  of  Figure  6.17  have  been 
evaluated in order to obtain NMR semiquantitative data. These can be computed by 
dividing  the  area  of  the  free  ligand  peak  by  the  total  area,  and  represent  the 
percentage of ligand being in its free form. These values can be compared with those 
obtained from potentiometric measurements. All results are summarized in Table 6.5. 
The potentiometric values differ from the NMR ones (due to several reasons, e.g. 
isotopic effects), but only at the intermediate pH the difference is significant. The 
percentage of free ligand appears to have been overestimated: this might be both due 
to the overlap of a complex signal and the free ligand signal, or to the undetection of 
a severely broadened signal of the complexes. To this connection, bis Al(III)-HPCs 
complexes are eligible to give broad signals at NMR because the interconversion of 
their possible diastereoisomers is known to be rather quick [Crisponi 2012 (b)].  
 
Table 6.5: free ligand percentage obtained by potentiometric results and 
1H-NMR spectra 
pH  Potentiometry (%) 
1H-NMR (%) 
2.65  85  80 
4.22  54  77 
5.17  46  40 
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7  CONCLUSIONS AND PERSPECTIVES 
The research project, in which this thesis work was performed, regards the design, 
synthesis  and study  of  hydroxypyridinecarboxylic acids  (HPCs)  as  new chelating 
agents for iron and aluminium. The aim is to create new HPC derivatives bearing the 
same positive properties as the HPCs studied up to now, but showing at the same 
time a higher complexation strength towards the two toxic metal ions. At the present 
stage of the project, hydroxypyridinedicarboxylic acids (HPdCs) have been identified 
as possible candidates, and two HPdC derivatives have been chosen for the studies, 
4-hydroxy-3,5-pyridinedicarboxylic  acid  (DQ58)  and  4-hydroxy-1-methyl-3,5-
pyridinedicarboxylic acid (DQ71508). The studies on DQ58 and DQ71508 which 
can be performed at  first  are purely chemical,  and regard the solution  speciation 
studies of solutions containing either ligand and either of the following metal ions: 
Fe(III), Al(III), Cu(II), Zn(II). Iron and aluminium should be studied in order to get 
the most important information, the metal-ligand affinity, which is likely correlated 
with the chelator efficiency in vivo. Copper and zinc speciation are important as well, 
because their metal-chelator affinity can be correlated with possible toxic side effects 
induced by the chelator (furthermore, if the zinc- and copper-ligand affinity were 
adequate, the chelator might be of interest for a metal-targeting therapy in Alzheimer 
disease). 
Among the eight possible combinations of ligand+metal systems which the chosen 
ligand and metal ions produce, the following were studied during this thesis work: 
DQ58-Zn(II),  DQ71508-Zn(II),  DQ71508-Cu(II),  and  (in  part)  DQ58-Cu(II).  For 
each Zn(II) system and for DQ71508-Cu(II), potentiometric data have been obtained, 
in which the final ligand-metal titrations have been preceded by the titrations of the 
ligand  and  of  the  metal  alone,  and  by  the  acid-base  titrations.  The  easy  of 
potentiometry to undergo systematic and random errors requested the potentiometric 
apparatus  to  be  continuously  and  accurately  checked  through  calibrations  and 
parameters comparison. Potentiometric titrations curves indicated the formation of 
very few complexes, which include only the 1:1 ligand-to-metal complex having one 
or two different protonation states. For all the above four systems, UV-Vis data have 
been obtained as well. 
1H NMR and EPR spectra have been recorded for ligand-
Zn(II) and ligand-Cu(II) solutions, respectively. 
No definitive result can be given, because most UV-Vis and all EPR spectra have not 
been elaborated yet, i.e., corresponding final results are still missing. These results 
can  be  very  important,  because  they  would  allow  to  clarify  the  metal-ligand 
speciation at physiological pH. In fact, UV-Vis appeared to reduce or overcome the 
precipitation  problem  encountered  in  all  ligand-metal  potentiometric  titrations  
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starting  from  acidic  pH  values.  Nevertheless,  the  obtained  potentiometric  data 
indicate that the Cu(II) and Zn(II) complexes should be very weak at physiological 
pH, thus possibly causing no essential metal depletion during a chelation therapy 
regiment. On the other hand, the potentiometric results obtained in other thesis works 
[Cassini 2012, Feltracco 2013], indicate that DQ58 and DQ71508 are good but not 
excellent iron and aluminium chelators, i.e., their Al(III) and Fe(III) complexation 
strength is high but still significantly lower than that of other chelators presently in 
use (such as Deferiprone). Were these results confirmed, it would result that DQ58 
and  DQ71508  cannot  be  proposed  either  for  the  aluminium  and  iron  chelation 
therapy, or for the metal-targeting therapy for copper and zinc. 
Beside the above described research project, another HPC has been considered, 4-
pyridoxic acid (POA), due to its biological relevance and to the interesting possibility 
to employ a well-known non-toxic compound as chelator. The following metal-POA 
have been studied in this thesis: POA-Zn(II) and POA-Al(III). Potentiometric data on 
POA-Zn(II)  indicated  no  complex  formation,  or  the  formation  of  very  weak 
complexes which could not be detected in solution. On the other hand, the solution 
speciation  of  POA-Al(III)  demonstrated  to  be  rather  complicated,  and  many 
complexes coexist in solution with ligand-to-metal stoichiometric ratios 1:1, 2:1, and 
3:1,  and  with  different  protonation  states.  The  complexes  formed  in  solution  are 
stable, so that the hydroxide precipitation is prevented by a ligand moderate excess. 
However,  the  Al(III)  affinity  of  POA  is  not  as  high  as  it  is  for  other  chelators 
presently in use.  
As work perspectives, the missing spectroscopic data have to be elaborated. Some 
results on the metal-ligand systems not included in this thesis, but included in the 
project, are being processed as well, and will allow to gain a full speciation picture of 
the systems examined in this project.  
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